# EDGAR Filing Document

**Accession Number:** 0001038509
**File Stem:** 0001038509-25-000049
**Filing Date:** 2025-11
**Character Count:** 307792
**Document Hash:** 0beea0a0cc6d9e5716a1514742475ece
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001038509-25-000049.hdr.sgml**: 20251107

**ACCESSION NUMBER**: 0001038509-25-000049

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251107

**DATE AS OF CHANGE**: 20251107

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRUCO LIFE INSURANCE OF NEW JERSEY
- **CENTRAL INDEX KEY:** 0001038509
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 222426091
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-18053
- **FILM NUMBER:** 251463676

**BUSINESS ADDRESS:**
- **STREET 1:** 213 WASHINGTON ST
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102
- **BUSINESS PHONE:** 9738022859

**MAIL ADDRESS:**
- **STREET 1:** 213 WASHINGTON ST
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07102

?xml version='1.0' encoding='ASCII'? cik1038509-20250930

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

 **UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

________________________________________

**FORM 10-Q** 

________________________________________

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025** 

OR

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the Transition Period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission File Number 333-18053** 

____________________________________________________________

**Pruco Life Insurance Company of New Jersey**

(Exact Name of Registrant as Specified in its Charter)

---

| | |
|:---|:---|
| **New Jersey** | **22-2426091** |
| **(State or Other Jurisdiction of<br>Incorporation or Organization)** | **(I.R.S. Employer Identification Number)** |

---

**213 Washington Street** 

**Newark, NJ 07102** 

**(973) 802-6000** 

**(Address and Telephone Number of Registrant's Principal Executive Offices)**

**SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:**

---

| | | |
|:---|:---|:---|
| **<u>Title of Each Class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of Each Exchange on Which Registered</u>** |
| Not Applicable | Not Applicable | Not Applicable |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller Reporting Company | ☐ |
| | | Emerging Growth Company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

As of November 7, 2025, 400,000 shares of the registrant's Common Stock (par value $5) were outstanding. As of such date, Pruco Life Insurance Company, an Arizona corporation, owned all of the registrant's Common Stock.

**Pruco Life Insurance Company of New Jersey meets the conditions set**

**forth in General Instruction (H) (1) (a) and (b) on Form 10-Q and**

**is therefore filing this Form 10-Q in the reduced disclosure format.**

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page<br>Number** |
| **[PART I—FINANCIAL INFORMATION](#i3359dcf7e2124b3a87e46a6d66ad7397_13)** | **[PART I—FINANCIAL INFORMATION](#i3359dcf7e2124b3a87e46a6d66ad7397_13)** | |
| Item 1. | [Financial Statements:](#i3359dcf7e2124b3a87e46a6d66ad7397_16) |  |
|  | [Unaudited Interim Statements of Financial Position as of](#i3359dcf7e2124b3a87e46a6d66ad7397_19)[September](#i3359dcf7e2124b3a87e46a6d66ad7397_19)[30, 2025 and December 31, 2024](#i3359dcf7e2124b3a87e46a6d66ad7397_19) | [4](#i3359dcf7e2124b3a87e46a6d66ad7397_19) |
|  | [Unaudited Interim Statements of Operations and Comprehensive Income (Loss) for the three and](#i3359dcf7e2124b3a87e46a6d66ad7397_22)[nine](#i3359dcf7e2124b3a87e46a6d66ad7397_22)[months ended](#i3359dcf7e2124b3a87e46a6d66ad7397_22)[September](#i3359dcf7e2124b3a87e46a6d66ad7397_22)[30, 2025 and 2024](#i3359dcf7e2124b3a87e46a6d66ad7397_22) | [5](#i3359dcf7e2124b3a87e46a6d66ad7397_22) |
|  | [Unaudited Interim Statements of Equity for the three and](#i3359dcf7e2124b3a87e46a6d66ad7397_25)[nine](#i3359dcf7e2124b3a87e46a6d66ad7397_25)[months ended](#i3359dcf7e2124b3a87e46a6d66ad7397_25)[September](#i3359dcf7e2124b3a87e46a6d66ad7397_25)[30, 2025 and 2024](#i3359dcf7e2124b3a87e46a6d66ad7397_25) | [6](#i3359dcf7e2124b3a87e46a6d66ad7397_25) |
|  | [Unaudited Interim Statements of Cash Flows for the](#i3359dcf7e2124b3a87e46a6d66ad7397_28)[nine](#i3359dcf7e2124b3a87e46a6d66ad7397_28)[months ended](#i3359dcf7e2124b3a87e46a6d66ad7397_28)[September](#i3359dcf7e2124b3a87e46a6d66ad7397_28)[30, 2025 and 2024](#i3359dcf7e2124b3a87e46a6d66ad7397_28) | [7](#i3359dcf7e2124b3a87e46a6d66ad7397_28) |
|  | [Notes to Unaudited Interim Financial Statements](#i3359dcf7e2124b3a87e46a6d66ad7397_31) | [9](#i3359dcf7e2124b3a87e46a6d66ad7397_31) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[1.&nbsp;&nbsp;&nbsp;&nbsp;Business and Basis of Presentation](#i3359dcf7e2124b3a87e46a6d66ad7397_34) | [9](#i3359dcf7e2124b3a87e46a6d66ad7397_34) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[2.&nbsp;&nbsp;&nbsp;&nbsp;Significant Accounting Policies and Pronouncements](#i3359dcf7e2124b3a87e46a6d66ad7397_37) | [10](#i3359dcf7e2124b3a87e46a6d66ad7397_37) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[3.&nbsp;&nbsp;&nbsp;&nbsp;Investments](#i3359dcf7e2124b3a87e46a6d66ad7397_40) | [11](#i3359dcf7e2124b3a87e46a6d66ad7397_40) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[4.&nbsp;&nbsp;&nbsp;&nbsp;Derivatives and Hedging](#i3359dcf7e2124b3a87e46a6d66ad7397_43) | [22](#i3359dcf7e2124b3a87e46a6d66ad7397_43) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[5.&nbsp;&nbsp;&nbsp;&nbsp;Fair Value of Assets and Liabilities](#i3359dcf7e2124b3a87e46a6d66ad7397_46) | [28](#i3359dcf7e2124b3a87e46a6d66ad7397_46) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[6. Deferred Policy Acquisition Costs and Deferred Reinsurance](#i3359dcf7e2124b3a87e46a6d66ad7397_49) | [40](#i3359dcf7e2124b3a87e46a6d66ad7397_49) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[7.&nbsp;&nbsp;&nbsp;&nbsp;Separate Accounts](#i3359dcf7e2124b3a87e46a6d66ad7397_58) | [42](#i3359dcf7e2124b3a87e46a6d66ad7397_58) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[8.&nbsp;&nbsp;&nbsp;&nbsp;Liability for Future Policy Benefits](#i3359dcf7e2124b3a87e46a6d66ad7397_61) | [43](#i3359dcf7e2124b3a87e46a6d66ad7397_61) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[9.&nbsp;&nbsp;&nbsp;&nbsp;Policyholders' Account Balances](#i3359dcf7e2124b3a87e46a6d66ad7397_82) | [50](#i3359dcf7e2124b3a87e46a6d66ad7397_82) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[10. Market Risk Benefits](#i3359dcf7e2124b3a87e46a6d66ad7397_85) | [53](#i3359dcf7e2124b3a87e46a6d66ad7397_85) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[11. Reinsurance](#i3359dcf7e2124b3a87e46a6d66ad7397_88) | [55](#i3359dcf7e2124b3a87e46a6d66ad7397_88) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[12. Income Taxes](#i3359dcf7e2124b3a87e46a6d66ad7397_91) | [60](#i3359dcf7e2124b3a87e46a6d66ad7397_91) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[13. Equity](#i3359dcf7e2124b3a87e46a6d66ad7397_94) | [60](#i3359dcf7e2124b3a87e46a6d66ad7397_94) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[14. Related Party Transactions](#i3359dcf7e2124b3a87e46a6d66ad7397_97) | [62](#i3359dcf7e2124b3a87e46a6d66ad7397_97) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[15. Commitments and Contingent Liabilities](#i3359dcf7e2124b3a87e46a6d66ad7397_109) | [65](#i3359dcf7e2124b3a87e46a6d66ad7397_109) |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i3359dcf7e2124b3a87e46a6d66ad7397_115) | [67](#i3359dcf7e2124b3a87e46a6d66ad7397_115) |
| Item 4. | [Controls and Procedures](#i3359dcf7e2124b3a87e46a6d66ad7397_154) | [74](#i3359dcf7e2124b3a87e46a6d66ad7397_154) |
| **[PART II—OTHER INFORMATION](#i3359dcf7e2124b3a87e46a6d66ad7397_157)** | **[PART II—OTHER INFORMATION](#i3359dcf7e2124b3a87e46a6d66ad7397_157)** | [75](#i3359dcf7e2124b3a87e46a6d66ad7397_157) |
| Item 1. | [Legal Proceedings](#i3359dcf7e2124b3a87e46a6d66ad7397_160) | [75](#i3359dcf7e2124b3a87e46a6d66ad7397_160) |
| Item 1A. | [Risk Factors](#i3359dcf7e2124b3a87e46a6d66ad7397_163) | [75](#i3359dcf7e2124b3a87e46a6d66ad7397_163) |
| Item 6. | [Exhibits](#i3359dcf7e2124b3a87e46a6d66ad7397_166) | [76](#i3359dcf7e2124b3a87e46a6d66ad7397_166) |
| **[SIGNATURES](#i3359dcf7e2124b3a87e46a6d66ad7397_169)** | **[SIGNATURES](#i3359dcf7e2124b3a87e46a6d66ad7397_169)** | [77](#i3359dcf7e2124b3a87e46a6d66ad7397_169) |

---

2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**FORWARD-LOOKING STATEMENTS**

Certain of the statements included in this Quarterly Report on Form 10-Q, constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "expects," "believes," "anticipates," "includes," "plans," "assumes," "estimates," "projects," "intends," "should," "will," "shall" or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management's current expectations and beliefs concerning future developments and their potential effects upon Pruco Life Insurance Company of New Jersey and its subsidiary. There can be no assurance that future developments affecting Pruco Life Insurance Company of New Jersey and its subsidiary will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (1) losses on investments or financial contracts due to deterioration in credit quality or value, or counterparty default; (2) losses on insurance products due to mortality experience or policyholder behavior experience that differs significantly from our expectations when we price our products; (3) changes in interest rates and equity prices that may (a) adversely impact the profitability of our products, the value of separate accounts supporting these products or the value of assets we manage, (b) result in losses on derivatives we use to hedge risk or increase collateral posting requirements and (c) limit opportunities to invest at appropriate returns; (4) guarantees within certain of our products which are market sensitive and may decrease our earnings or increase the volatility of our results of operations or financial position; (5) liquidity needs resulting from (a) derivative collateral market exposure, (b) asset/liability mismatches, (c) the lack of available funding in the financial markets or (d) unexpected cash demands due to severe mortality calamity or lapse events; (6) financial or customer losses, or regulatory and legal actions, due to inadequate or failed processes or systems, external events and human error or misconduct such as (a) disruption of our systems and data, (b) an information security breach, (c) a failure to protect the privacy of sensitive data (d) reliance on third-parties or (e) labor and employment matters; (7) changes in the regulatory landscape, including related to (a) financial sector regulatory reform, (b) changes in tax laws, (c) fiduciary rules and other standards of care, (d) state insurance laws and developments regarding group-wide supervision, capital and reserves, and (e) privacy and cybersecurity regulation; (8) technological changes which may adversely impact companies in our investment portfolio or cause insurance experience to deviate from our assumptions; (9) ratings downgrades; (10) market conditions that may adversely affect the sales or persistency of our products; (11) competition; (12) reputational damage; and (13) the impact on the Company of a continued shutdown of the U.S. government. Pruco Life Insurance Company of New Jersey does not intend, and is under no obligation, to update any particular forward-looking statement included in this document. See "Risk Factors" included in the Annual Report on Form 10-K for the year ended December 31, 2024 for discussion of certain risks relating to our business and investment in our securities.

3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**PART I—FINANCIAL INFORMATION**

**Item 1. *Financial Statements***

**PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY**

**Unaudited Interim Statements of Financial Position**

**September 30, 2025 and December 31, 2024 (in thousands, except share amounts)**

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **ASSETS** | | |
| Fixed maturities, available for sale, at fair value (allowance for credit losses: 2025-$472; 2024-$0) (amortized cost: 2025-$3,575,236; 2024-$3,024,155)  | $3381615 | $2716937 |
| Fixed maturities, trading, at fair value (amortized cost: 2025-$22,145; 2024-$23,955) | 22486 | 21252 |
| Equity securities, at fair value (cost: 2025-$80,633; 2024-$353) | 81324 | 62 |
| Policy loans | 1121275 | 1118589 |
| Short-term investments | 2237 | 11394 |
| Commercial mortgage and other loans (net of $2,771 and $1,713 allowance for credit losses at September 30, 2025 and December 31, 2024, respectively) | 672111 | 477328 |
| Other invested assets (includes $114,260 and $55,624 of assets measured at fair value at September 30, 2025 and December 31, 2024, respectively) | 304676 | 233212 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments | 5585724 | 4578774 |
| Cash and cash equivalents | 144963 | 170825 |
| Deferred policy acquisition costs | 460176 | 417316 |
| Accrued investment income | 55337 | 60368 |
| Reinsurance recoverables and deposit receivables (includes $394,728 and $265,611 of embedded derivatives at fair value at September 30, 2025 and December 31, 2024, respectively) | 5687885 | 4929428 |
| Receivables from parent and affiliates | 54075 | 70766 |
| Income tax assets | 100616 | 113718 |
| Market risk benefit assets | 496751 | 492444 |
| Other assets | 83846 | 76876 |
| Separate account assets | 15015462 | 14507553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $27684835 | $25418068 |
| **LIABILITIES AND EQUITY** |  |  |
| **LIABILITIES** |  |  |
| Policyholders' account balances | $5755807 | $4928299 |
| Future policy benefits | 2703432 | 2517483 |
| Market risk benefit liabilities | 496751 | 492444 |
| Reinsurance payables | 2079148 | 1440264 |
| Payables to parent and affiliates | 168 | 462 |
| Other liabilities | 289698 | 281973 |
| Separate account liabilities | 15015462 | 14507553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 26340466 | 24168478 |
| **COMMITMENTS AND CONTINGENT LIABILITIES (See Note 15)** |  |  |
| **EQUITY** |  |  |
| Common stock ($5 par value; 400,000 shares authorized, issued and outstanding) | 2000 | 2000 |
| Additional paid-in capital | 1037569 | 1032513 |
| Retained earnings | 382074 | 350494 |
| Accumulated other comprehensive income (loss) | (77274) | (135417) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 1344369 | 1249590 |
| **TOTAL LIABILITIES AND EQUITY** | $27684835 | $25418068 |

---

**See Notes to Unaudited Interim Financial Statements**

4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY**

**Unaudited Interim Statements of Operations and Comprehensive Income (Loss)**

**Three and Nine Months Ended September 30, 2025 and 2024 (in thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **REVENUES** |  |  |  |  |
| Premiums (includes $(18), $47, $5 and $117 of gains (losses) from changes in estimates on deferred profit liability amortization for the three months ended September 30, 2025 and 2024 and the nine months ended September 30, 2025 and 2024, respectively)  | $11523 | $11711 | $34207 | $34197 |
| Policy charges and fee income | 27307 | 21073 | 69286 | 375690 |
| Net investment income | 69973 | 56997 | 193227 | 158818 |
| Asset administration fees | 3355 | 2937 | 9442 | 8176 |
| Other income (loss) | 3172 | 4177 | 9466 | 8328 |
| Realized investment gains (losses), net | (40771) | (36690) | (155934) | (48288) |
| Change in value of market risk benefits, net of related hedging gains (losses) | 21264 | (5333) | 6672 | 10520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL REVENUES** | 95823 | 54872 | 166366 | 547441 |
| **BENEFITS AND EXPENSES** |  |  |  |  |
| Policyholders' benefits | 7991 | (3548) | 55235 | 564099 |
| Change in estimates of liability for future policy benefits | 3271 | (1040) | (17001) | (5224) |
| Interest credited to policyholders' account balances | 21814 | 19212 | 39965 | 60410 |
| Amortization of deferred policy acquisition costs | 4395 | 5387 | 14368 | (14749) |
| General, administrative and other expenses | 12711 | 10937 | 39159 | 33439 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL BENEFITS AND EXPENSES** | 50182 | 30948 | 131726 | 637975 |
| **INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES** | 45641 | 23924 | 34640 | (90534) |
| &nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 3977 | 10012 | 3060 | (31174) |
| **NET INCOME (LOSS)** | $41664 | $13912 | $31580 | $(59360) |
| Other comprehensive income (loss), before tax: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency translation adjustments | (28) | 269 | 673 | 184 |
| &nbsp;&nbsp;Net unrealized investment gains (losses) | 47932 | 111826 | 83941 | 33396 |
| &nbsp;&nbsp;Interest rate remeasurement of future policy benefits | (4476) | (14695) | (4368) | (1894) |
| &nbsp;&nbsp;Gain (loss) from changes in non-performance risk on market risk benefits | (21262) | 5333 | (6670) | (10520) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 22166 | 102733 | 73576 | 21166 |
| &nbsp;&nbsp;&nbsp;Less: Income tax expense (benefit) related to other comprehensive income (loss) | 4651 | 21574 | 15433 | 4445 |
| Other comprehensive income (loss), net of taxes | 17515 | 81159 | 58143 | 16721 |
| **Comprehensive income (loss)** | $59179 | $95071 | $89723 | $(42639) |

---

**See Notes to Unaudited Interim Financial Statements**

5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY**

**Unaudited Interim Statements of Equity**

**Three and Nine Months Ended September 30, 2025 and 2024 (in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total Equity** |
| **Balance, December 31, 2024** | $2000 | $1032513 | $350494 | $(135417) | $1249590 |
| Comprehensive income (loss): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | (6979) |  | (6979) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax |  |  |  | 31849 | 31849 |
| Total comprehensive income (loss) |  |  | (6979) | 31849 | 24870 |
| **Balance, March 31, 2025** | 2000 | 1032513 | 343515 | (103568) | 1274460 |
| Contributed capital |  | 1500 |  |  | 1500 |
| Comprehensive income (loss): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | (3105) |  | (3105) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax |  |  |  | 8779 | 8779 |
| Total comprehensive income (loss) |  |  | (3105) | 8779 | 5674 |
| **Balance, June 30, 2025** | 2000 | 1034013 | 340410 | (94789) | 1281634 |
| Contributed capital |  | 3556 |  |  | 3556 |
| Comprehensive income (loss): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | 41664 |  | 41664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of taxes |  |  |  | 17515 | 17515 |
| Total comprehensive income (loss) |  |  | 41664 | 17515 | 59179 |
| **Balance, September 30, 2025** | $2000 | $1037569 | $382074 | $(77274) | $1344369 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total Equity** |
| **Balance, December 31, 2023** | $2000 | $1032513 | $381140 | $(47527) | $1368126 |
| Comprehensive income (loss): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | (79390) |  | (79390) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax |  |  |  | (46038) | (46038) |
| Total comprehensive income (loss) |  |  | (79390) | (46038) | (125428) |
| **Balance, March 31, 2024** | 2000 | 1032513 | 301750 | (93565) | 1242698 |
| Comprehensive income (loss): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | 6118 |  | 6118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax |  |  |  | (18400) | (18400) |
| Total comprehensive income (loss) |  |  | 6118 | (18400) | (12282) |
| **Balance, June 30, 2024** | 2000 | 1032513 | 307868 | (111965) | 1230416 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  |  | 13912 |  | 13912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax |  |  |  | 81159 | 81159 |
| Total comprehensive income (loss) |  |  | 13912 | 81159 | 95071 |
| **Balance, September 30, 2024** | $2000 | $1032513 | $321780 | $(30806) | $1325487 |

---

**See Notes to Unaudited Interim Financial Statements**

6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

**PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY**

**Unaudited Interim Statements of Cash Flows**

**Nine Months Ended September 30, 2025 and 2024 (in thousands)**

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net income (loss) | $31580 | $(59360) |
| &nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Policy charges and fee income(1) | (13460) | (14826) |
| &nbsp;&nbsp;&nbsp;Interest credited to policyholders' account balances | 39965 | 60410 |
| &nbsp;&nbsp;&nbsp;Realized investment (gains) losses, net | 155934 | 48288 |
| &nbsp;&nbsp;Change in value of market risk benefits, net of related hedging (gains) losses | (6672) | (10520) |
| &nbsp;&nbsp;&nbsp;Change in: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future policy benefits and other insurance liabilities | 204935 | 219342 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reinsurance related-balances(1) | (197584) | 22260 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued investment income | 5031 | 5533 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net payables to (receivables from) parent and affiliates | 11875 | 32847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred policy acquisition costs(1) | (42860) | (43296) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes | (2330) | (28511) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives, net | 34462 | 35902 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net(1) | (24003) | (95020) |
| **Cash flows from (used in) operating activities** | 196873 | 173049 |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| Proceeds from the sale/maturity/prepayment of: |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, available-for-sale | 187420 | 86927 |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | 9844 | 1346 |
| &nbsp;&nbsp;&nbsp;Equity securities | 2 | 188 |
| &nbsp;&nbsp;&nbsp;Policy loans | 29619 | 23030 |
| &nbsp;&nbsp;&nbsp;Ceded policy loans | (2777) | (25103) |
| &nbsp;&nbsp;&nbsp;Short-term investments | 11345 | 17795 |
| &nbsp;&nbsp;&nbsp;Commercial mortgage and other loans | 11392 | 4423 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 16316 | 829 |
| &nbsp;&nbsp;&nbsp;Notes receivable from parent and affiliates(1) | 13062 | 0 |
| Payments for the purchase/origination of: |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, available-for-sale | (715808) | (316009) |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | (8951) | 0 |
| &nbsp;&nbsp;&nbsp;Equity securities | (80282) | (273) |
| &nbsp;&nbsp;&nbsp;Policy loans | (26926) | (23661) |
| &nbsp;&nbsp;&nbsp;Ceded policy loans | 3542 | 2688 |
| &nbsp;&nbsp;&nbsp;Short-term investments | (2274) | (28521) |
| &nbsp;&nbsp;&nbsp;Commercial mortgage and other loans | (203010) | (132908) |
| &nbsp;&nbsp;&nbsp;Other invested assets | (33955) | (44388) |
| &nbsp;&nbsp;&nbsp;Notes receivable from parent and affiliates(1) | (8469) | (29234) |
| Derivatives, net | (1039) | (47) |
| Other, net | 106 | 0 |
| **Cash flows from (used in) investing activities** | (800843) | (462918) |

---

7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account deposits | 897909 | 788735 |
| &nbsp;&nbsp;&nbsp;Affiliated ceded policyholders' account deposits | (247948) | (264370) |
| &nbsp;&nbsp;&nbsp;Policyholders' account withdrawals | (334551) | (308204) |
| &nbsp;&nbsp;&nbsp;Affiliated ceded policyholders' account withdrawals | 223466 | 231490 |
| &nbsp;&nbsp;&nbsp;Drafts outstanding | 5066 | (6210) |
| &nbsp;&nbsp;&nbsp;Other, net | 34166 | 24592 |
| **Cash flows from (used in) financing activities** | 578108 | 466033 |
| **NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS** | (25862) | 176164 |
| **CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR** | 170825 | 186383 |
| **CASH AND CASH EQUIVALENTS, END OF PERIOD** | $144963 | $362547 |

---

(1)Prior period amounts have been updated to conform to current period presentation.

**<u>Significant Non-Cash Transactions</u>**

**<u>2025</u>**

There were no significant non-cash transactions for the nine months ended September 30, 2025.

**<u>2024</u>**

"Cash flows from (used in) operating activities" for the nine months ended September 30, 2024 excludes certain non-cash activities in the amount of $193 million related to the affiliated reinsurance transaction with Prudential Universal Reinsurance Entity Company ("PURE") and The Prudential Insurance Company of America ("Prudential Insurance"), effective January 1, 2024. See Note 11 for additional information.

**See Notes to Unaudited Interim Financial Statements**

8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements** |

---

**1.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS AND BASIS OF PRESENTATION**

Pruco Life Insurance Company of New Jersey (the "Company" or "PLNJ") is a wholly-owned subsidiary of Pruco Life Insurance Company ("Pruco Life"), which in turn is a wholly-owned subsidiary of Prudential Insurance. Prudential Insurance is a direct wholly-owned subsidiary of Prudential Financial, Inc. ("Prudential Financial"). PLNJ is a stock life insurance company organized in 1982 under the laws of the State of New Jersey. It is licensed to sell life insurance and annuities in New Jersey and New York only, and sells such products primarily through affiliated and unaffiliated distributors.

***Basis of Presentation***

The Unaudited Interim Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission ("SEC"). Intercompany balances and transactions have been eliminated.

In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company's Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

***Segment Information***

Although there are separate products within PLNJ, the Company is organized as a single reportable segment and manages the business activities on a total entity basis. The accounting policies are the same as those described in Note 2 included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The Company analyzes operating performance using "Income (loss) from operations before income taxes", as determined in accordance with U.S. GAAP. This is the measure of profit or loss used by the Company's chief operating decision maker to evaluate performance and allocate resources. The measure of segment assets is reported as "Total Assets" on the Statements of Financial Position. Segment revenue is reported as "Total Revenues" on the Statements of Operations and Comprehensive Income (Loss). As the Company has one reportable segment, there are no intersegment revenues. The Company discloses all significant expense categories separately on the Statements of Operations and Comprehensive Income (Loss).

The Company's chief operating decision maker is a group of Prudential Financial executives that include the chief financial officer, controller, treasurer, and business leaders, which include the Company's chief executive officer and chief financial officer. Overall business decisions for the Company are made by this group of executives. Such business decisions include the allocation of capital, distribution/sale of products, and allocation/deployment of overall Prudential Financial resources.

***Use of Estimates***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The most significant estimates include those used in determining future policy benefits; policyholders' account balances and reinsurance related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits ("MRBs"); the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments; reinsurance recoverables; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters.

***Reclassifications***

Certain amounts in prior periods have been reclassified to conform to the current period presentation.

9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**2.&nbsp;&nbsp;&nbsp;&nbsp;SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS**

***Recent Accounting Pronouncements***

Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASUs") to the FASB Accounting Standards Codification ("ASC"). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of September 30, 2025, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material.

***ASUs issued but not yet adopted as of September 30, 2025***

---

| | | | |
|:---|:---|:---|:---|
| **Standard** | **Description** | **Effective date and method of adoption** | **Effect on the financial statements or other significant matters** |
| *ASU 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses* | This ASU requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in the notes to financial statements. | The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted, and should be applied either prospectively or retrospectively. | The Company is currently assessing the impact of the ASU on the Company's Financial Statements and Notes to the Financial Statements. |
| *ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures* | This ASU requires entities to provide additional information primarily related to the effective tax rate reconciliation and income taxes paid. | Effective for fiscal years beginning after December 15, 2024, and permits early adoption. | The ASU has no impact on the Company's Financial Statements but will result in expanded disclosures in the Notes to the Financial Statements. |

---

10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**3.&nbsp;&nbsp;&nbsp;&nbsp;INVESTMENTS**

***Fixed Maturity Securities***

The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Allowance for Credit Losses** | **Fair<br>Value** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $51580 | $1 | $1101 | $0 | $50480 |
| Obligations of U.S. states and their political subdivisions | 138047 | 110 | 8836 | 0 | 129321 |
| Foreign government securities | 88132 | 341 | 15294 | 0 | 73179 |
| U.S. public corporate securities | 1937971 | 21439 | 177158 | 0 | 1782252 |
| U.S. private corporate securities | 418855 | 8898 | 5960 | 0 | 421793 |
| Foreign public corporate securities | 419276 | 6392 | 23969 | 0 | 401699 |
| Foreign private corporate securities | 281916 | 16599 | 11667 | 472 | 286376 |
| Asset-backed securities(1) | 134678 | 540 | 398 | 0 | 134820 |
| Commercial mortgage-backed securities | 89562 | 501 | 3435 | 0 | 86628 |
| Residential mortgage-backed securities(2) | 15219 | 175 | 327 | 0 | 15067 |
| &nbsp;&nbsp;&nbsp;Total fixed maturities, available-for-sale | $3575236 | $54996 | $248145 | $472 | $3381615 |

---

(1)Includes credit-tranched securities collateralized by loan obligations, home equity, education loans and auto loans.

(2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Amortized<br>Cost** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Allowance for Credit Losses** | **Fair<br>Value** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $51847 | $0 | $3041 | $0 | $48806 |
| Obligations of U.S. states and their political subdivisions | 156065 | 23 | 9308 | 0 | 146780 |
| Foreign government securities | 85052 | 10 | 19308 | 0 | 65754 |
| U.S. public corporate securities | 1759560 | 4794 | 217474 | 0 | 1546880 |
| U.S. private corporate securities | 297278 | 1963 | 10499 | 0 | 288742 |
| Foreign public corporate securities | 258728 | 799 | 30374 | 0 | 229153 |
| Foreign private corporate securities | 256820 | 2059 | 20465 | 0 | 238414 |
| Asset-backed securities(1) | 46956 | 196 | 532 | 0 | 46620 |
| Commercial mortgage-backed securities | 96459 | 0 | 5437 | 0 | 91022 |
| Residential mortgage-backed securities(2) | 15390 | 148 | 772 | 0 | 14766 |
| &nbsp;&nbsp;&nbsp;Total fixed maturities, available-for-sale | $3024155 | $9992 | $317210 | $0 | $2716937 |

---

(1)Includes credit-tranched securities collateralized by loan obligations, education loans and auto loans.

(2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.

11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Less Than Twelve Months** | **Less Than Twelve Months** | **Twelve Months or More** | **Twelve Months or More** | **Total** | **Total** |
| | **Fair Value** | **Gross<br>Unrealized<br>Losses** | **Fair Value** | **Gross<br>Unrealized<br>Losses** | **Fair Value** | **Gross<br>Unrealized<br>Losses** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $0 | $0 | $50100 | $1101 | $50100 | $1101 |
| Obligations of U.S. states and their political subdivisions | 36109 | 1480 | 78521 | 7356 | 114630 | 8836 |
| Foreign government securities | 0 | 0 | 61492 | 15294 | 61492 | 15294 |
| U.S. public corporate securities | 54502 | 3493 | 923238 | 173665 | 977740 | 177158 |
| U.S. private corporate securities | 35903 | 290 | 117606 | 5670 | 153509 | 5960 |
| Foreign public corporate securities | 27391 | 111 | 132016 | 23858 | 159407 | 23969 |
| Foreign private corporate securities | 21899 | 762 | 53898 | 10905 | 75797 | 11667 |
| Asset-backed securities | 4250 | 2 | 5602 | 396 | 9852 | 398 |
| Commercial mortgage-backed securities | 0 | 0 | 71127 | 3435 | 71127 | 3435 |
| Residential mortgage-backed securities | 22 | 0 | 11640 | 327 | 11662 | 327 |
| &nbsp;&nbsp;&nbsp;Total fixed maturities, available-for-sale | $180076 | $6138 | $1505240 | $242007 | $1685316 | $248145 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Less Than Twelve Months** | **Less Than Twelve Months** | **Twelve Months or More** | **Twelve Months or More** | **Total** | **Total** |
| | **Fair Value** | **Gross<br>Unrealized<br>Losses** | **Fair Value** | **Gross<br>Unrealized<br>Losses** | **Fair Value** | **Gross<br>Unrealized<br>Losses** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $383 | $3 | $48423 | $3038 | $48806 | $3041 |
| Obligations of U.S. states and their political subdivisions | 67690 | 2057 | 74006 | 7251 | 141696 | 9308 |
| Foreign government securities | 3464 | 129 | 61163 | 19179 | 64627 | 19308 |
| U.S. public corporate securities | 427698 | 12874 | 894799 | 204600 | 1322497 | 217474 |
| U.S. private corporate securities | 68806 | 1038 | 107275 | 9461 | 176081 | 10499 |
| Foreign public corporate securities | 68181 | 2154 | 108111 | 28220 | 176292 | 30374 |
| Foreign private corporate securities | 78262 | 2590 | 84669 | 17875 | 162931 | 20465 |
| Asset-backed securities | 2143 | 12 | 6914 | 520 | 9057 | 532 |
| Commercial mortgage-backed securities | 0 | 0 | 91022 | 5437 | 91022 | 5437 |
| Residential mortgage-backed securities | 148 | 4 | 10729 | 768 | 10877 | 772 |
| &nbsp;&nbsp;&nbsp;Total fixed maturities, available-for-sale | $716775 | $20861 | $1487111 | $296349 | $2203886 | $317210 |

---

12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

As of September 30, 2025 and December 31, 2024, the gross unrealized losses on fixed maturity, available-for-sale securities without an allowance of $247 million and $313 million, respectively, related to "1" highest quality or "2" high quality securities based on the National Association of Insurance Commissioners ("NAIC") or equivalent rating and $1 million and $4 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of September 30, 2025, the $242 million of gross unrealized losses of twelve months or more were concentrated in the Company's corporate securities within the consumer non-cyclical, utility, and finance sectors. As of December 31, 2024, the $296 million of gross unrealized losses of twelve months or more were concentrated in the Company's corporate securities within the utility, consumer non-cyclical and finance sectors.

In accordance with its policy described in Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at September 30, 2025. This conclusion was based on a detailed analysis of the underlying credit and cash flows for each security. Gross unrealized losses are primarily attributable to increases in interest rates, general credit spread widening and foreign currency exchange rate movements. As of September 30, 2025, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis.

The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** |
| | **Amortized Cost** | **Fair Value** |
| | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | |
| Due in one year or less | $66681 | $66457 |
| Due after one year through five years | 848546 | 864413 |
| Due after five years through ten years | 764781 | 785638 |
| Due after ten years | 1655769 | 1428592 |
| Asset-backed securities | 134678 | 134820 |
| Commercial mortgage-backed securities | 89562 | 86628 |
| Residential mortgage-backed securities | 15219 | 15067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturities, available-for-sale | $3575236 | $3381615 |

---

Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date.

13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from sales(1) | $34147 | $5444 | $65609 | $8718 |
| &nbsp;&nbsp;&nbsp;Proceeds from maturities/prepayments | 46471 | 23712 | 122880 | 78189 |
| &nbsp;&nbsp;&nbsp;Gross investment gains from sales and maturities | 396 | 163 | 907 | 428 |
| &nbsp;&nbsp;&nbsp;Gross investment losses from sales and maturities | (1705) | (1006) | (3151) | (1510) |
| &nbsp;&nbsp;&nbsp;(Addition to) release of allowance for credit losses | (472) | 155 | (472) | (52) |

---

(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $(1.1) million and $0.0 million for the nine months ended September 30, 2025 and 2024, respectively.

The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **U.S. Treasury Securities and Obligations of U.S. States** | **Foreign Government Securities** | **U.S. and Foreign Corporate Securities** | **Asset-Backed Securities** | **Commercial Mortgage-Backed Securities** | **Residential Mortgage-Backed Securities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| &nbsp;&nbsp;&nbsp;Additions to allowance for credit losses not previously recorded | 0 | 0 | 472 | 0 | 0 | 0 | 472 |
| &nbsp;&nbsp;&nbsp;Additions (reductions) on securities with previous allowance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $0 | $0 | $472 | $0 | $0 | $0 | $472 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **U.S. Treasury Securities and Obligations of U.S. States** | **Foreign Government Securities** | **U.S. and Foreign Corporate Securities** | **Asset-Backed Securities** | **Commercial Mortgage-Backed Securities** | **Residential Mortgage-Backed Securities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | $0 | $0 | $209 | $0 | $0 | $2 | $211 |
| &nbsp;&nbsp;&nbsp;Additions to allowance for credit losses not previously recorded | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Additions (reductions) on securities with previous allowance | 0 | 0 | (153) | 0 | 0 | (2) | (155) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $0 | $0 | $56 | $0 | $0 | $0 | $56 |

---

14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **U.S. Treasury Securities and Obligations of U.S. States** | **Foreign Government Securities** | **U.S. and Foreign Corporate Securities** | **Asset-Backed Securities** | **Commercial Mortgage-Backed Securities** | **Residential Mortgage-Backed Securities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| &nbsp;&nbsp;&nbsp;Additions to allowance for credit losses not previously recorded | 0 | 0 | 491 | 0 | 0 | 0 | 491 |
| &nbsp;&nbsp;&nbsp;Additions (reductions) on securities with previous allowance | 0 | 0 | (19) | 0 | 0 | 0 | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $0 | $0 | $472 | $0 | $0 | $0 | $472 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **U.S. Treasury Securities and Obligations of U.S. States** | **Foreign Government Securities** | **U.S. and Foreign Corporate Securities** | **Asset-Backed Securities** | **Commercial Mortgage-Backed Securities** | **Residential Mortgage-Backed Securities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | |
| &nbsp;&nbsp;&nbsp;Balance, beginning of period | $0 | $0 | $0 | $0 | $0 | $4 | $4 |
| &nbsp;&nbsp;&nbsp;Additions to allowance for credit losses not previously recorded | 0 | 0 | 209 | 0 | 0 | 2 | 211 |
| &nbsp;&nbsp;&nbsp;Additions (reductions) on securities with previous allowance | 0 | 0 | (153) | 0 | 0 | (6) | (159) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance, end of period | $0 | $0 | $56 | $0 | $0 | $0 | $56 |

---

For additional information regarding the Company's methodology for developing its allowance and expected losses, see Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

For the three months ended September 30, 2025, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to net additions within the consumer cyclical sector within corporate securities primarily due to adverse projected cash flows. For the three months ended September 30, 2024, the net decrease in the allowance for credit losses on available-for-sale securities was primarily related to a net release within the communications sector within corporate securities due to a recovery.

For the nine months ended September 30, 2025, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to net additions within the consumer cyclical sector within corporate securities primarily due to adverse projected cash flows. For the nine months ended September 30, 2024, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to a net addition in the communications sector within corporate securities due to adverse projected cash flows.

The Company did not have any fixed maturity securities purchased with credit deterioration as of both September 30, 2025 and December 31, 2024.

***Fixed Maturities, Trading***

The net change in unrealized gains (losses) from fixed maturities, trading still held at period end, recorded within "Other income (loss)," was less than $1.0 million and $1.2 million during the three months ended September 30, 2025 and 2024, respectively, and $2.1 million and $0.9 million during the nine months ended September 30, 2025 and 2024, respectively.

15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Equity Securities***

The net change in unrealized gains (losses) from equity securities still held at period end, recorded within "Other income (loss)," was $1.0 million and $0.3 million during the three months ended September 30, 2025 and 2024, respectively, and $1.0 million and $(0.2) million during the nine months ended September 30, 2025 and 2024, respectively.

***Commercial Mortgage and Other Loans***

The following table sets forth the composition of "Commercial mortgage and other loans", as of the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Amount** | **% of<br>Total** | **Amount** | **% of<br>Total** |
| | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| **Commercial mortgage and agricultural property loans by property type:** | | | | |
| Apartments/Multi-Family | $220605 | 32.7% | $136607 | 28.5% |
| Health Care Senior Living(1) | 3000 | 0.4 | 3000 | 0.7 |
| Hospitality | 11614 | 1.7 | 11981 | 2.5 |
| Industrial | 208110 | 30.8 | 166012 | 34.6 |
| Office | 6715 | 1.0 | 6706 | 1.4 |
| Retail | 71595 | 10.6 | 51092 | 10.7 |
| Self-Storage(1) | 57190 | 8.5 | 33762 | 7.0 |
| Other(1) | 8593 | 1.3 | 8593 | 1.8 |
| &nbsp;&nbsp;&nbsp;Total commercial mortgage loans | 587422 | 87.0 | 417753 | 87.2 |
| Agricultural property loans | 87460 | 13.0 | 61288 | 12.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total commercial mortgage and agricultural property loans | 674882 | 100.0% | 479041 | 100.0% |
| Allowance for credit losses | (2771) |  | (1713) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net commercial mortgage and agricultural property loans | $672111 |  | $477328 |  |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Prior period amounts have been updated to conform to current period presentation.

As of September 30, 2025, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States with the largest concentrations in Florida (18%), California (13%) and Washington (7%) and included loans secured by properties in Europe (6%) and Mexico (1%).

The following tables set forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Commercial Mortgage Loans** | **Agricultural Property Loans** | **Total** | **Commercial Mortgage Loans** | **Agricultural Property Loans** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Allowance, beginning of period** | $2037 | $106 | $2143 | $1056 | $44 | $1100 |
| Addition to (release of) allowance for expected losses | 576 | 52 | 628 | 397 | 6 | 403 |
| **Allowance, end of period** | $2613 | $158 | $2771 | $1453 | $50 | $1503 |

---

16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Commercial Mortgage Loans** | **Agricultural Property Loans** | **Total** | **Commercial Mortgage Loans** | **Agricultural Property Loans** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Allowance, beginning of period** | $1670 | $43 | $1713 | $1107 | $55 | $1162 |
| Addition to (release of) allowance for expected losses | 943 | 115 | 1058 | 346 | (5) | 341 |
| **Allowance, end of period** | $2613 | $158 | $2771 | $1453 | $50 | $1503 |

---

For additional information regarding the Company's methodology for developing its allowance and expected losses, see Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

For both the three months ended September 30, 2025 and 2024, the net increase in the allowance for credit losses on commercial mortgage and other loans was in the general reserve primarily related to loan originations.

For both the nine months ended September 30, 2025 and 2024, the net increase in the allowance for credit losses on commercial mortgage and other loans was in the general reserve primarily related to loan originations.

17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** |
| | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |  |
| Loan-to-Value Ratio: |  |  |  |  |  |  |  |  |
| 0%-59.99% | $53511 | $66481 | $12676 | $29629 | $2351 | $66105 | $0 | $230753 |
| 60%-69.99% | 114784 | 109105 | 61202 | 4941 | 347 | 18334 | 0 | 308713 |
| 70%-79.99% | 8309 | 23602 | 6297 | 0 | 0 | 2310 | 0 | 40518 |
| 80% or greater | 0 | 0 | 0 | 0 | 0 | 7438 | 0 | 7438 |
| &nbsp;&nbsp;&nbsp;**Total** | $176604 | $199188 | $80175 | $34570 | $2698 | $94187 | $0 | $587422 |
| Debt Service Coverage Ratio: |  |  |  |  |  |  |  |  |
| Greater than 1.2x | $169173 | $192845 | $63229 | $34570 | $2698 | $85801 | $0 | $548316 |
| 1.0 - 1.2x | 4180 | 3824 | 16946 | 0 | 0 | 8386 | 0 | 33336 |
| Less than 1.0x | 3251 | 2519 | 0 | 0 | 0 | 0 | 0 | 5770 |
| &nbsp;&nbsp;&nbsp;**Total** | $176604 | $199188 | $80175 | $34570 | $2698 | $94187 | $0 | $587422 |
| **Agricultural property loans** |  |  |  |  |  |  |  |  |
| Loan-to-Value Ratio: |  |  |  |  |  |  |  |  |
| 0%-59.99% | $20197 | $32000 | $10921 | $13305 | $968 | $849 | $1724 | $79964 |
| 60%-69.99% | 3769 | 0 | 2000 | 0 | 0 | 0 | 1727 | 7496 |
| 70%-79.99% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 80% or greater | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $23966 | $32000 | $12921 | $13305 | $968 | $849 | $3451 | $87460 |
| Debt Service Coverage Ratio: |  |  |  |  |  |  |  |  |
| Greater than 1.2x | $23966 | $31000 | $12921 | $960 | $968 | $849 | $3451 | $74115 |
| 1.0 - 1.2x | 0 | 1000 | 0 | 0 | 0 | 0 | 0 | 1000 |
| Less than 1.0x | 0 | 0 | 0 | 12345 | 0 | 0 | 0 | 12345 |
| &nbsp;&nbsp;&nbsp;**Total** | $23966 | $32000 | $12921 | $13305 | $968 | $849 | $3451 | $87460 |

---

18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** | **Amortized Cost by Origination Year** |
| | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Commercial mortgage loans** |  |  |  |  |  |  |  |  |
| Loan-to-Value Ratio: |  |  |  |  |  |  |  |  |
| 0%-59.99% | $65002 | $9312 | $19739 | $2367 | $2198 | $68971 | $0 | $167589 |
| 60%-69.99% | 115394 | 62665 | 15000 | 347 | 0 | 20157 | 0 | 213563 |
| 70%-79.99% | 19060 | 6355 | 0 | 0 | 0 | 6416 | 0 | 31831 |
| 80% or greater | 0 | 0 | 0 | 0 | 0 | 4770 | 0 | 4770 |
| &nbsp;&nbsp;&nbsp;**Total** | $199456 | $78332 | $34739 | $2714 | $2198 | $100314 | $0 | $417753 |
| Debt Service Coverage Ratio: |  |  |  |  |  |  |  |  |
| Greater than 1.2x | $195535 | $71280 | $34739 | $2714 | $2198 | $95444 | $0 | $401910 |
| 1.0 - 1.2x | 3921 | 7052 | 0 | 0 | 0 | 4870 | 0 | 15843 |
| Less than 1.0x | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $199456 | $78332 | $34739 | $2714 | $2198 | $100314 | $0 | $417753 |
| **Agricultural property loans** |  |  |  |  |  |  |  |  |
| Loan-to-Value Ratio: |  |  |  |  |  |  |  |  |
| 0%-59.99% | $32130 | $10875 | $992 | $1002 | $0 | $904 | $1040 | $46943 |
| 60%-69.99% | 0 | 2000 | 12345 | 0 | 0 | 0 | 0 | 14345 |
| 70%-79.99% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 80% or greater | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $32130 | $12875 | $13337 | $1002 | $0 | $904 | $1040 | $61288 |
| Debt Service Coverage Ratio: |  |  |  |  |  |  |  |  |
| Greater than 1.2x | $31130 | $12875 | $13337 | $1002 | $0 | $904 | $1040 | $60288 |
| 1.0 - 1.2x | 1000 | 0 | 0 | 0 | 0 | 0 | 0 | 1000 |
| Less than 1.0x | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $32130 | $12875 | $13337 | $1002 | $0 | $904 | $1040 | $61288 |

---

For additional information regarding the Company's commercial mortgage and other loans credit quality monitoring process, see Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Current** | **30-59 Days Past Due** | **60-89 Days Past Due** | **90 Days or More Past Due(1)** | **Total Loans** | **Non-Accrual Status(2)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Commercial mortgage loans | $587422 | $0 | $0 | $0 | $587422 | $0 |
| Agricultural property loans | 87460 | 0 | 0 | 0 | 87460 | 0 |
| &nbsp;&nbsp;&nbsp;Total | $674882 | $0 | $0 | $0 | $674882 | $0 |

---

(1)As of September 30, 2025, there were no loans in this category accruing interest.

(2)For additional information regarding the Company's policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

.

19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Current** | **30-59 Days Past Due** | **60-89 Days Past Due** | **90 Days or More Past Due(1)** | **Total Loans** | **Non-Accrual Status(2)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Commercial mortgage loans | $417753 | $0 | $0 | $0 | $417753 | $0 |
| Agricultural property loans | 61288 | 0 | 0 | 0 | 61288 | 0 |
| &nbsp;&nbsp;&nbsp;Total | $479041 | $0 | $0 | $0 | $479041 | $0 |

---

(1)As of December 31, 2024, there were no loans in this category accruing interest.

(2)For additional information regarding the Company's policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

For both the three months ended September 30, 2025 and 2024, there were no commercial mortgage and other loans acquired, respectively, other than those through direct origination, and there were no commercial mortgage and other loans sold.

For the nine months ended September 30, 2025 and 2024 there were $0.0 million and $12.6 million commercial mortgage and other loans acquired, other than those through direct origination, and there were no commercial mortgage and other loans sold.

The Company did not have any commercial mortgage and other loans purchased with credit deterioration as of both September 30, 2025 and December 31, 2024.

***Other Invested Assets***

The following table sets forth the composition of "Other invested assets," as of the dates indicated:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| LPs/LLCs: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity method: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity | $108950 | $112001 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hedge funds | 74563 | 58312 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate-related | 6903 | 7118 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal equity method | 190416 | 177431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity | 181 | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hedge funds | 1 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate-related | 3469 | 3492 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal fair value | 3651 | 3694 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total LPs/LLCs | 194067 | 181125 |
| Derivative instruments | 110609 | 51930 |
| Other(1) | 0 | 157 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other invested assets | $304676 | $233212 |

---

(1) Includes tax advantaged investments.

20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Accrued Investment Income***

The following table sets forth the composition of "Accrued investment income," as of the dates indicated:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| &nbsp;&nbsp;&nbsp;Fixed maturities | $37102 | $32587 |
| &nbsp;&nbsp;&nbsp;Commercial mortgage and other loans | 3051 | 1980 |
| &nbsp;&nbsp;&nbsp;Policy loans | 14490 | 25110 |
| &nbsp;&nbsp;&nbsp;Short-term investments and cash equivalents | 694 | 691 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total accrued investment income | $55337 | $60368 |

---

There were no write-downs on accrued investment income for both the three and nine months ended September 30, 2025 and 2024.

***Net Investment Income***

The following table sets forth "Net investment income" by investment type, for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Fixed maturities, available-for-sale | $41606 | $30979 | $117279 | $87612 |
| Fixed maturities, trading | 164 | 146 | 680 | 442 |
| Equity securities | 241 | 91 | 241 | 273 |
| Commercial mortgage and other loans | 9116 | 4721 | 23528 | 11643 |
| Policy loans | 12844 | 13387 | 38791 | 39421 |
| Other invested assets | 5597 | 4556 | 12427 | 12297 |
| Short-term investments and cash equivalents | 2235 | 4556 | 5759 | 11212 |
| &nbsp;&nbsp;&nbsp;Gross investment income | 71803 | 58436 | 198705 | 162900 |
| Less: investment expenses | (1830) | (1439) | (5478) | (4082) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net investment income | $69973 | $56997 | $193227 | $158818 |

---

21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Realized Investment Gains (Losses), Net***

The following table sets forth "Realized investment gains (losses), net" by investment type, for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Fixed maturities(1) | $(1781) | $(688) | $(2716) | $(1134) |
| Commercial mortgage and other loans | (628) | (403) | (1058) | (341) |
| LPs/LLCs(2) | 0 | 1 | 0 | (35) |
| Derivatives | (12917) | (4460) | (89192) | (15590) |
| Short-term investments and cash equivalents | 8 | 5 | 15 | (43) |
| Ceded income on modified coinsurance assets(2)(3) | (25452) | (31145) | (62986) | (31145) |
| Other(2) | (1) | 0 | 3 | 0 |
| &nbsp;&nbsp;&nbsp;Realized investment gains (losses), net | $(40771) | $(36690) | $(155934) | $(48288) |

---

(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading.

(2)Prior period amounts have been updated to conform to current period presentation.

(3)Includes changes in the value of reinsurance payables and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties.

***Net Unrealized Gains (Losses) on Investments within AOCI***

The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| Fixed maturity securities, available-for-sale with an allowance | $5 | $(19) |
| Fixed maturity securities, available-for-sale without an allowance | (193154) | (307199) |
| Derivatives designated as cash flow hedges(1) | (5902) | 12310 |
| Other investments | 349 | 288 |
| &nbsp;&nbsp;&nbsp;Net unrealized gains (losses) on investments | $(198702) | $(294620) |

---

(1) For additional information regarding cash flow hedges, see Note 4.

***Repurchase Agreements and Securities Lending***

In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. As of both September 30, 2025 and December 31, 2024, the Company had no repurchase agreements and no securities lending transactions.

**4.&nbsp;&nbsp;&nbsp;&nbsp;DERIVATIVES AND HEDGING** 

***Types of Derivative Instruments and Derivative Strategies***

The Company utilizes various derivative instruments and strategies to manage its risk. Commonly used derivative instruments include, but are not necessarily limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest rate contracts: futures, swaps, options, caps and floors

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Equity contracts: futures, options and total return swaps

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Foreign exchange contracts: futures, options, forwards and swaps

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Credit contracts: single and index reference credit default swaps

22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

Other types of financial contracts that the Company accounts for as derivatives include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Embedded derivatives

For detailed information on these contracts and the related strategies, see Note 4 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

***Primary Risks Managed by Derivatives***

The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables and deposit receivables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| **Primary Underlying Risk/Instrument Type** | | **Fair Value** | **Fair Value** | | **Fair Value** | **Fair Value** |
| **Primary Underlying Risk/Instrument Type** |<br>**Gross Notional** | **Assets** | **Liabilities** |<br>**Gross Notional** | **Assets** | **Liabilities** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Derivatives Designated as Hedge Accounting Instruments:** | | | | | | |
| &nbsp;&nbsp;&nbsp;**Currency/Interest Rate** | | | | | | |
| &nbsp;&nbsp;&nbsp;Foreign Currency Swaps | $270176 | $5758 | $(15712) | $225884 | $13344 | $(1391) |
| **Total Derivatives Designated as Hedge Accounting Instruments:** | $270176 | $5758 | $(15712) | $225884 | $13344 | $(1391) |
| **Derivatives Not Qualifying as Hedge Accounting Instruments:**  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Interest Rate** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest Rate Swaps | $1421600 | $5496 | $(12700) | $484200 | $2649 | $(6417) |
| &nbsp;&nbsp;&nbsp;**Credit** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit Default Swaps | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;**Currency/Interest Rate** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign Currency Swaps | 27691 | 1046 | (1096) | 33693 | 2782 | (216) |
| &nbsp;&nbsp;&nbsp;**Foreign Currency** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign Currency Forwards | 24815 | 144 | (28) | 12198 | 527 | 0 |
| &nbsp;&nbsp;&nbsp;**Equity** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity Total Return Swaps | 809260 | 86333 | (87215) | 450000 | 28166 | (28166) |
| &nbsp;&nbsp;&nbsp;Equity Options | 5298864 | 319674 | (197044) | 2930701 | 107964 | (70799) |
| **Total Derivatives Not Qualifying as Hedge Accounting Instruments:** | $7582230 | $412693 | $(298083) | $3910792 | $142088 | $(105598) |
| **Total Derivatives(1)(2)** | $7852406 | $418451 | $(313795) | $4136676 | $155432 | $(106989) |

---

(1)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $433 million and $241 million as of September 30, 2025 and December 31, 2024, respectively included in "Policyholders' account balances" and "Reinsurance recoverables and deposit receivables".

(2)Recorded in "Other invested assets" and "Payables to parent and affiliates" on the Unaudited Interim Statements of Financial Position.

23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Offsetting Assets and Liabilities***

The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Statements of Financial Position.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Gross<br>Amounts of<br>Recognized<br>Financial<br>Instruments** | **Gross<br>Amounts<br>Offset in the <br>Statements of<br>Financial<br>Position** | **Net Amounts<br>Presented in<br>the Statements<br>of Financial<br>Position** | **Financial<br>Instruments/<br>Collateral(1)** | **Net<br>Amount** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Offsetting of Financial Assets:** | | | | | |
| Derivatives | $418451 | $(307842) | $110609 | $(103605) | $7004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $418451 | $(307842) | $110609 | $(103605) | $7004 |
| **Offsetting of Financial Liabilities:** |  |  |  |  |  |
| Derivatives | $313795 | $(313795) | $0 | $0 | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | $313795 | $(313795) | $0 | $0 | $0 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross<br>Amounts of<br>Recognized<br>Financial<br>Instruments** | **Gross<br>Amounts<br>Offset in the <br>Statements of<br>Financial<br>Position** | **Net Amounts<br>Presented in<br>the Statements<br>of Financial<br>Position** | **Financial<br>Instruments/<br>Collateral(1)** | **Net<br>Amount** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Offsetting of Financial Assets:** | | | | | |
| Derivatives | $155432 | $(103502) | $51930 | $(51421) | $509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $155432 | $(103502) | $51930 | $(51421) | $509 |
| **Offsetting of Financial Liabilities:** |  |  |  |  |  |
| Derivatives | $106989 | $(106989) | $0 | $0 | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | $106989 | $(106989) | $0 | $0 | $0 |

---

(1) Amounts exclude the excess of collateral received/pledged from/to the counterparty.

For information regarding the rights of offset associated with the derivative assets and liabilities in the table above see "Credit Risk" below and Note 14.

24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Cash Flow Hedges***

The primary derivative instruments used by the Company in its cash flow hedge accounting relationships are currency swaps. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit or equity derivatives in any of its cash flow hedge accounting relationships.

The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Realized<br>Investment<br>Gains (Losses)** | **Change in Value of Market Risk Benefits, Net of Related Hedging Gains (Losses)** | **Net<br>Investment<br>Income** | **Other Income (Loss)** | **Change in AOCI** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Derivatives Designated as Hedge Accounting Instruments:** | | | | | |
| **Cash flow hedges** | | | | | |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | $(122) | $0 | $664 | $161 | $2473 |
| &nbsp;&nbsp;&nbsp;Total cash flow hedges | (122) | 0 | 664 | 161 | 2473 |
| **Derivatives Not Qualifying as Hedge Accounting Instruments:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest Rate | (467) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency | 178 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | 415 | 0 | 0 | (8) | 0 |
| &nbsp;&nbsp;&nbsp;Equity | 98153 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Embedded Derivatives | (111074) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Total Derivatives Not Qualifying as Hedge Accounting Instruments | (12795) | 0 | 0 | (8) | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $(12917) | $0 | $664 | $153 | $2473 |

---

25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Realized<br>Investment<br>Gains (Losses)** | **Change in Value of Market Risk Benefits, Net of Related Hedging Gains (Losses)** | **Net<br>Investment<br>Income** | **Other Income (Loss)** | **Change in AOCI** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Derivatives Designated as Hedge Accounting Instruments:** | | | | | |
| **Cash flow hedges** | | | | | |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | $1039 | $0 | $2141 | $(4325) | $(18212) |
| &nbsp;&nbsp;&nbsp;Total cash flow hedges | 1039 | 0 | 2141 | (4325) | (18212) |
| **Derivatives Not Qualifying as Hedge Accounting Instruments:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest Rate | (11872) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency | (1569) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | (1776) | 0 | 0 | (41) | 0 |
| &nbsp;&nbsp;&nbsp;Equity | 125889 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Embedded Derivatives | (200903) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Total Derivatives Not Qualifying as Hedge Accounting Instruments | (90231) | 0 | 0 | (41) | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $(89192) | $0 | $2141 | $(4366) | $(18212) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Realized<br>Investment<br>Gains (Losses)** | **Change in Value of Market Risk Benefits, Net of Related Hedging Gains (Losses)** | **Net<br>Investment<br>Income** | **Other Income (Loss)** | **Change in AOCI** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Derivatives Designated as Hedge Accounting Instruments:** | | | | | |
| **Cash flow hedges** | | | | | |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | $19 | $0 | $607 | $(1589) | $(6413) |
| &nbsp;&nbsp;&nbsp;Total cash flow hedges | 19 | 0 | 607 | (1589) | (6413) |
| **Derivatives Not Qualifying as Hedge Accounting Instruments:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest Rate | (400) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency | (484) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | (946) | 0 | 0 | (21) | 0 |
| &nbsp;&nbsp;&nbsp;Equity | 11450 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Embedded Derivatives | (14099) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Total Derivatives Not Qualifying as Hedge Accounting Instruments | (4479) | 0 | 0 | (21) | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $(4460) | $0 | $607 | $(1610) | $(6413) |

---

26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Realized<br>Investment<br>Gains (Losses)** | **Change in Value of Market Risk Benefits, Net of Related Hedging Gains (Losses)** | **Net<br>Investment<br>Income** | **Other Income (Loss)** | **Change in AOCI** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Derivatives Designated as Hedge Accounting Instruments:** | | | | | |
| **Cash flow hedges** | | | | | |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | $(321) | $0 | $1670 | $(1014) | $(1676) |
| &nbsp;&nbsp;&nbsp;Total cash flow hedges | (321) | 0 | 1670 | (1014) | (1676) |
| **Derivatives Not Qualifying as Hedge Accounting Instruments:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest Rate | 1276 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency | (217) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | (23) | 0 | 0 | (13) | 0 |
| &nbsp;&nbsp;&nbsp;Equity | 62466 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Embedded Derivatives | (78771) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Total Derivatives Not Qualifying as Hedge Accounting Instruments | (15269) | 0 | 0 | (13) | 0 |
| &nbsp;&nbsp;&nbsp;**Total** | $(15590) | $0 | $1670 | $(1027) | $(1676) |

---

.

Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:

---

| | |
|:---|:---|
| | **(in thousands)** |
| **Balance, December 31, 2024** | $12310 |
| Amount recorded in AOCI |  |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | (19357) |
| **Total amount recorded in AOCI** | (19357) |
| Amount reclassified from AOCI to income |  |
| &nbsp;&nbsp;&nbsp;Currency/Interest Rate | 1145 |
| **Total amount reclassified from AOCI to income** | 1145 |
| **Balance, September 30, 2025** | $(5902) |

---

The changes in fair value of cash flow hedges are deferred in AOCI and are included in "Net unrealized investment gains (losses)" in the Unaudited Interim Statements of Operations and Comprehensive Income (Loss); these amounts are then reclassified to earnings when the hedged item affects earnings. Using September 30, 2025 values, it is estimated that a pre-tax gain of $2.3 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending September 30, 2026.

The exposures the Company is hedging with these qualifying cash flow hedges include the variability of the payment or receipt of interest or foreign currency amounts on existing financial instruments.

There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging.

27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Credit Derivatives***

The Company has no exposure from credit derivative positions where it has written or purchased credit protection as of September 30, 2025 and December 31, 2024.

***Counterparty Credit Risk***

The Company is exposed to credit-related losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by entering into derivative transactions with regulated derivatives exchanges for exchange traded derivatives and its affiliate, Prudential Global Funding LLC ("PGF"), related to its over-the-counter ("OTC") derivatives. PGF, in turn, manages its credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single-party credit exposures which are subject to periodic management review.

Substantially all of the Company's derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position.

**5.&nbsp;&nbsp;&nbsp;&nbsp;FAIR VALUE OF ASSETS AND LIABILITIES** 

**Fair Value Measurement** – Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:

Level 1 – Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities.

Level 2 – Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs.

Level 3 – Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value.

For a discussion of the Company's valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 5 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. There have been no material changes in our valuation techniques during the period represented by these Unaudited Interim Financial Statements.

28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**Assets and Liabilities by Hierarchy Level** – The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Level 1** | **Level 2** | **Level 3** | **Netting(1)** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Fixed maturities, available-for-sale: |  |  |  |  |  |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $0 | $50480 | $0 | $ | $50480 |
| Obligations of U.S. states and their political subdivisions | 0 | 129321 | 0 |  | 129321 |
| Foreign government securities | 0 | 73179 | 0 |  | 73179 |
| U.S. corporate public securities | 0 | 1782252 | 0 |  | 1782252 |
| U.S. corporate private securities | 0 | 409354 | 12439 |  | 421793 |
| Foreign corporate public securities | 0 | 401699 | 0 |  | 401699 |
| Foreign corporate private securities | 0 | 280184 | 6192 |  | 286376 |
| Asset-backed securities(2) | 0 | 122769 | 12051 |  | 134820 |
| Commercial mortgage-backed securities | 0 | 67751 | 18877 |  | 86628 |
| Residential mortgage-backed securities | 0 | 15067 | 0 |  | 15067 |
| &nbsp;&nbsp;&nbsp;Subtotal | 0 | 3332056 | 49559 |  | 3381615 |
| Market risk benefit assets | 0 | 0 | 496751 |  | 496751 |
| Fixed maturities, trading | 0 | 18722 | 3764 |  | 22486 |
| Equity securities | 80986 | 338 | 0 |  | 81324 |
| Short-term investments | 0 | 2237 | 0 |  | 2237 |
| Cash equivalents | 0 | 144760 | 0 |  | 144760 |
| Other invested assets(3) | 0 | 418451 | 0 | (307842) | 110609 |
| Reinsurance recoverables and deposit receivables | 0 | 0 | 394728 |  | 394728 |
| Receivables from parent and affiliates | 0 | 3582 | 21961 |  | 25543 |
| &nbsp;&nbsp;Subtotal excluding separate account assets | 80986 | 3920146 | 966763 | (307842) | 4660053 |
| Separate account assets(4)(5) | 0 | 13672903 | 0 |  | 13672903 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $80986 | $17593049 | $966763 | $(307842) | $18332956 |
| Market risk benefit liabilities | $0 | $0 | $496751 | $ | $496751 |
| Policyholders' account balances | 0 | 0 | 827537 |  | 827537 |
| Payables to parent and affiliates | 0 | 313795 | 0 | (313795) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $0 | $313795 | $1324288 | $(313795) | $1324288 |

---

29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Level 1** | **Level 2** | **Level 3** | **Netting(1)** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Fixed maturities, available-for-sale: |  |  |  |  |  |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | $0 | $48806 | $0 | $ | $48806 |
| Obligations of U.S. states and their political subdivisions | 0 | 146780 | 0 |  | 146780 |
| Foreign government securities | 0 | 65754 | 0 |  | 65754 |
| U.S. corporate public securities | 0 | 1546880 | 0 |  | 1546880 |
| U.S. corporate private securities | 0 | 275923 | 12819 |  | 288742 |
| Foreign corporate public securities | 0 | 229153 | 0 |  | 229153 |
| Foreign corporate private securities | 0 | 232200 | 6214 |  | 238414 |
| Asset-backed securities(2) | 0 | 41070 | 5550 |  | 46620 |
| Commercial mortgage-backed securities | 0 | 72544 | 18478 |  | 91022 |
| Residential mortgage-backed securities | 0 | 14766 | 0 |  | 14766 |
| &nbsp;&nbsp;&nbsp;Subtotal | 0 | 2673876 | 43061 |  | 2716937 |
| Market risk benefit assets | 0 | 0 | 492444 |  | 492444 |
| Fixed maturities, trading | 0 | 21252 | 0 |  | 21252 |
| Equity securities | 0 | 62 | 0 |  | 62 |
| Short-term investments | 0 | 10222 | 172 |  | 10394 |
| Cash equivalents | 0 | 167579 | 0 |  | 167579 |
| Other invested assets(3) | 0 | 155432 | 0 | (103502) | 51930 |
| Reinsurance recoverables and deposit receivables | 0 | 0 | 265611 |  | 265611 |
| Receivables from parent and affiliates | 0 | 0 | 30136 |  | 30136 |
| &nbsp;&nbsp;Subtotal excluding separate account assets | 0 | 3028423 | 831424 | (103502) | 3756345 |
| Separate account assets(4)(5) | 0 | 13251913 | 0 |  | 13251913 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $0 | $16280336 | $831424 | $(103502) | $17008258 |
| Market risk benefit liabilities | $0 | $0 | $492444 | $ | $492444 |
| Policyholders' account balances | 0 | 0 | 506305 |  | 506305 |
| Payables to parent and affiliates | 0 | 106989 | 0 | (106989) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $0 | $106989 | $998749 | $(106989) | $998749 |

---

(1)"Netting" amounts represent cash collateral of $(6) million and $(3) million as of September 30, 2025 and December 31, 2024, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements.

(2)Includes credit-tranched securities collateralized by loan obligations, home equity, education loans and auto loans.

(3)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of both September 30, 2025 and December 31, 2024, the fair value of such investments was $3.7 million.

(4)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate-owned life insurance fund. As of September 30, 2025 and December 31, 2024, the fair value of such investments was $1,343 million and $1,256 million, respectively.

(5)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Unaudited Interim Statements of Financial Position.

30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities** – The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Fair Value** | **Valuation <br>Techniques** | **Unobservable <br>Inputs** | **Minimum** | **Maximum** | **Weighted<br>Average** | **Impact of Increase in Input on Fair<br>Value(1)(2)** |
| | **(in thousands)** | **(in thousands)** | | | | | |
| **Assets:** | | | | | | | |
| Corporate securities(3) | $17150 | Discounted cash flow | Discount rate | 8.11% | 12.97% | 10.28% | Decrease |
| Commercial mortgage-backed securities | $18877 | Discounted cash flow | Liquidity premium | 0.90% | 0.90% | 0.90% | Decrease |
| Market risk benefit assets(4) | $496751 | Discounted cash flow | Lapse rate(5) | 1% | 20% |  | Increase |
|  |  |  | Spread over SOFR(6) | 0.33% | 1.65% |  | Increase |
|  |  |  | Utilization rate(7) | 37% | 94% |  | Decrease |
|  |  |  | Withdrawal rate | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. |
|  |  |  | Mortality rate(9) | 0% | 16% |  | Increase |
|  |  |  | Equity volatility curve | 15% | 25% |  | Decrease |
| Reinsurance recoverables and deposit receivables | $394728 | Discounted cash flow | Lapse rate(5) | 0% | 80% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.33% | 1.65% |  | Decrease |
|  |  |  | Option budget(11) | (2)% | 9% |  | Increase |
| Receivables from parent and affiliates | $21961 | Liquidation | Liquidation value | 100% | 100% | 100% | Increase |
| **Liabilities:** |  |  |  |  |  |  |  |
| Market risk benefit liabilities(4) | $496751 | Discounted cash flow | Lapse rate(5) | 1% | 20% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.33% | 1.65% |  | Decrease |
|  |  |  | Utilization rate(7) | 37% | 94% |  | Increase |
|  |  |  | Withdrawal rate | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. |
|  |  |  | Mortality rate(9) | 0% | 16% |  | Decrease |
|  |  |  | Equity volatility curve | 15% | 25% |  | Increase |
| Policyholders' account balances(10) | $827537 | Discounted cash flow | Lapse rate(5) | 0% | 80% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.33% | 1.65% |  | Decrease |
|  |  |  | Mortality rate(9) | 0% | 23% |  | Decrease |
|  |  |  | Option budget(11) | (2)% | 9% |  | Increase |

---

31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Fair Value** | **Valuation <br>Techniques** | **Unobservable Inputs** | **Minimum** | **Maximum** | **Weighted<br>Average** | **Impact of Increase<br>in Input on Fair<br>Value(1)(2)** |
| | **(in thousands)** | **(in thousands)** | | | | | |
| **Assets:** | | | | | | | |
| Corporate securities(3) | $16803 | Discounted cash flow | Discount rate | 8.74% | 13.91% | 11.72% | Decrease |
| Commercial mortgage-backed securities | $18478 | Discounted cash flow | Liquidity premium | 1.00% | 1.00% | 1.00% | Decrease |
| Market risk benefit assets(4) | $492444 | Discounted cash flow | Lapse rate(5) | 1% | 20% |  | Increase |
|  |  |  | Spread over SOFR(6) | 0.29% | 1.71% |  | Increase |
|  |  |  | Utilization rate(7) | 37% | 94% |  | Decrease |
|  |  |  | Withdrawal rate | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. |
|  |  |  | Mortality rate(9) | 0% | 16% |  | Increase |
|  |  |  | Equity volatility curve | 16% | 25% |  | Decrease |
| Reinsurance recoverables and deposit receivables | $265611 | Discounted cash flow | Lapse rate(5) | 0% | 80% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.29% | 1.71% |  | Decrease |
|  |  |  | Option budget(11) | (1)% | 7% |  | Increase |
| Receivables from parent and affiliates | $30136 | Liquidation | Liquidation value | 100% | 100% | 100% | Increase |
| **Liabilities:** |  |  |  |  |  |  |  |
| Market risk benefit liabilities(4) | $492444 | Discounted cash flow | Lapse rate(5) | 1% | 20% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.29% | 1.71% |  | Decrease |
|  |  |  | Utilization rate(7) | 37% | 94% |  | Increase |
|  |  |  | Withdrawal rate | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. | See table footnote (8) below. |
|  |  |  | Mortality rate(9) | 0% | 16% |  | Decrease |
|  |  |  | Equity volatility curve | 16% | 25% |  | Increase |
| Policyholders' account balances(10) | $506305 | Discounted cash flow | Lapse rate(5) | 0% | 80% |  | Decrease |
|  |  |  | Spread over SOFR(6) | 0.29% | 1.73% |  | Decrease |
|  |  |  | Mortality rate(9) | 0% | 23% |  | Decrease |
|  |  |  | Option budget(11) | (1)% | 7% |  | Increase |

---

(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table.

(2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs.

(3)Includes assets classified as fixed maturities available-for-sale.

(4)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

(5)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances.

(6)The spread over the Secured Overnight Financing Rate ("SOFR") swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company's estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of September 30, 2025 and December 31, 2024, respectively. This spread includes an estimate of non-performance risk ("NPR"), which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt.

32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

(7)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits.

(8)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both September 30, 2025 and December 31, 2024, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%.

(9)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age, and duration. A mortality improvement assumption is also incorporated into the overall mortality table.

(10)Policyholders' account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company's life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation.

(11)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives.

**Interrelationships Between Unobservable Inputs** – In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another or multiple inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows:

*Corporate Securities* – The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term, and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. During weaker economic cycles, as the expectations of default increase, credit spreads widen, which results in a decrease in fair value.

*Commercial Mortgage-backed Securities* – Interrelationships may exist between the prepayment rate, the default rate and/ or loss severity, depending on specific market conditions. In stronger economic cycles, prepayment rates are generally driven by underlying property appreciation and subsequent cash-out refinances, while default rates and loss severity may be lower. During weaker economic cycles, prepayment rates may decline, while default rates and loss severity increase. Generally, a change in the assumption used for the probability of default would be accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumption used for prepayment rates. The impact of these factors on average life and economics varies with the deal structure and tranche subordination.

*Market Risk Benefits* – The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is generally highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money.

33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**Changes in Level 3 Assets and Liabilities** – The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** | **Three Months Ended September 30, 2025(5)** |
| | **Fair Value, beginning of period** | **Total realized and unrealized gains (losses)** | **Purchases** | **Sales** | **Issuances** | **Settlements** | **Other** | **Transfers into Level 3(6)** | **Transfers out of Level 3(6)** | **Fair Value, end of period** | **Unrealized gains (losses) for assets still held(1)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;Corporate securities(2) | $20900 | $(321) | $156 | $(20) | $0 | $(2084) | $0 | $0 | $0 | $18631 | $(357) |
| &nbsp;&nbsp;&nbsp;Structured securities(3) | 29477 | 620 | 6488 | 0 | 0 | (107) | 0 | 0 | (5550) | 30928 | 628 |
| **Other assets:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | 1643 | 5 | 2116 | 0 | 0 | 0 | 0 | 0 | 0 | 3764 | 4 |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | (75) | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (75) |
| &nbsp;&nbsp;&nbsp;Short-term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(4) | 350331 | 2126 | 42271 | 0 | 0 | 0 | 0 | 0 | 0 | 394728 | (123999) |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 32529 | 0 | 0 | 0 | 0 | (10568) | 0 | 0 | 0 | 21961 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances(4) | (672210) | (113064) | 0 | 0 | (42263) | 0 | 0 | 0 | 0 | (827537) | 15237 |

---

34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** |
| | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** | **Net investment income** | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale** | $(466) | $0 | $774 | $(9) | $(472) | $0 | $743 |
| **Other assets:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | 0 | 5 | 0 | 0 | 0 | 4 | 0 |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | (75) | 0 | 0 | 0 | (75) | 0 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables | 2126 | 0 | 0 | 0 | (123999) | 0 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | (113064) | 0 | 0 | 0 | 15237 | 0 | 0 |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** | **Nine Months Ended September 30, 2025(5)** |
| | **Fair Value, beginning of period** | **Total realized and unrealized gains (losses)** | **Purchases** | **Sales** | **Issuances** | **Settlements** | **Other** | **Transfers into Level 3(6)** | **Transfers out of Level 3(6)** | **Fair Value, end of period** | **Unrealized gains (losses) for assets still held(1)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;Corporate securities(2) | $19033 | $152 | $3517 | $(886) | $0 | $(3185) | $0 | $0 | $0 | $18631 | $130 |
| &nbsp;&nbsp;&nbsp;Structured securities(3) | 24028 | 769 | 14338 | 0 | 0 | (357) | 0 | 0 | (7850) | 30928 | 797 |
| **Other assets:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | 0 | 69 | 3695 | 0 | 0 | 0 | 0 | 0 | 0 | 3764 | 69 |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | (75) | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (75) |
| &nbsp;&nbsp;&nbsp;Short-term investments | 172 | (23) | 174 | (137) | 0 | (186) | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(4) | 265611 | 7982 | 121135 | 0 | 0 | 0 | 0 | 0 | 0 | 394728 | (193277) |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 30136 | 0 | 4887 | (901) | 0 | (12161) | 0 | 0 | 0 | 21961 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances(4) | (506305) | (202356) | 0 | 0 | (118876) | 0 | 0 | 0 | 0 | (827537) | 4627 |

---

35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** |
| | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** | **Net investment income** | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** |
| | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| **Fixed maturities, available-for-sale** | $(478) | $0 | $1427 | $(28) | $(472) | $0 | $1399 |
| **Other assets:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturities, trading | 0 | 69 | 0 | 0 | 0 | 69 | 0 |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | (75) | 0 | 0 | 0 | (75) | 0 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 12 | 0 | (35) | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables | 7982 | 0 | 0 | 0 | (193277) | 0 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | (202356) | 0 | 0 | 0 | 4627 | 0 | 0 |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** | **Three Months Ended September 30, 2024(5)** |
| | **Fair Value, beginning of period** | **Total realized and unrealized gains (losses)** | **Purchases** | **Sales** | **Issuances** | **Settlements** | **Other(7)** | **Transfers into Level 3(6)** | **Transfers out of Level 3(6)** | **Fair Value, end of period** | **Unrealized gains (losses) for assets still held(1)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | |
| **Fixed maturities, available-for-sale:** | | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;Corporate securities(2) | $18798 | $203 | $655 | $0 | $0 | $(2212) | $0 | $0 | $0 | $17444 | $179 |
| &nbsp;&nbsp;&nbsp;Structured securities(3) | 24308 | 1092 | 0 | 0 | 0 | (97) | 0 | 0 | 0 | 25303 | 1093 |
| **Other assets:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity securities | 4320 | 327 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4647 | 327 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(4)(8) | 127289 | 17856 | 51231 | 0 | 0 | 0 | 5183 | 0 | 0 | 201559 | (26796) |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 16606 | 0 | 12628 | 0 | 0 | 0 | 0 | 0 | 0 | 29234 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances(4) | (351030) | (32059) | 0 | 0 | (54577) | 0 | 0 | 0 | 0 | (437666) | 14303 |

---

36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** |
| | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** | **Net investment income** | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale** | $1 | $0 | $1295 | $(1) | $0 | $0 | $1272 |
| **Other assets:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | 327 | 0 | 0 | 0 | 327 | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(8) | 17856 | 0 | 0 | 0 | (26796) | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | (32059) | 0 | 0 | 0 | 14303 | 0 | 0 |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** | **Nine Months Ended September 30, 2024(5)** |
| | **Fair Value, beginning of period** | **Total realized and unrealized gains (losses)** | **Purchases** | **Sales** | **Issuances** | **Settlements** | **Other(7)** | **Transfers into Level 3(6)** | **Transfers out of Level 3(6)** | **Fair Value, end of period** | **Unrealized gains (losses) for assets still held(1)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale:** | | | | | | | | | | | |
| &nbsp;&nbsp;&nbsp;Corporate securities(2) | $19629 | $105 | $5954 | $(87) | $0 | $(2607) | $(5550) | $0 | $0 | $17444 | $83 |
| &nbsp;&nbsp;&nbsp;Structured securities(3) | 19204 | 872 | 0 | 0 | 0 | (323) | 5550 | 0 | 0 | 25303 | 892 |
| **Other assets:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity securities | 4541 | (167) | 273 | 0 | 0 | 0 | 0 | 0 | 0 | 4647 | (167) |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(4)(8) | 69745 | (7851) | 134482 | 0 | 0 | 0 | 5183 | 0 | 0 | 201559 | (105510) |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 0 | 0 | 33924 | (4690) | 0 | 0 | 0 | 0 | 0 | 29234 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances(4) | (237316) | (70920) | 0 | 0 | (129430) | 0 | 0 | 0 | 0 | (437666) | 31819 |

---

37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Total realized and unrealized gains (losses)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** | **Unrealized gains (losses) for assets still held(1)** |
| | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** | **Net investment income** | **Realized investment gains (losses), net** | **Other income (loss)** | **Included in other comprehensive income (loss)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed maturities, available-for-sale** | $0 | $0 | $998 | $(21) | $0 | $0 | $975 |
| **Other assets:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity securities | 0 | (167) | 0 | 0 | 0 | (167) | 0 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables(8) | (7851) | 0 | 0 | 0 | (105510) | 0 | 0 |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| **Liabilities:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances | (70920) | 0 | 0 | 0 | 31819 | 0 | 0 |

---

(1)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts.

(2)Includes U.S. corporate private securities and foreign corporate private securities.

(3)Includes asset-backed and commercial mortgage-backed securities.

(4)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward.

(5)Excludes MRB assets of $497 million and $528 million and MRB liabilities of $497 million and $528 million for the periods ended September 30, 2025 and 2024, respectively. See Note 10 for additional information.

(6)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.

(7)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities.

(8)Prior period amounts have been updated to conform to current period presentation.

38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**Fair Value of Financial Instruments**

The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company's Unaudited Interim Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Carrying<br>Amount(1)** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;Commercial mortgage and other loans | $0 | $0 | $682902 | $682902 | $672111 |
| &nbsp;&nbsp;&nbsp;Policy loans | 0 | 0 | 1121275 | 1121275 | 1121275 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 203 | 0 | 0 | 203 | 203 |
| &nbsp;&nbsp;&nbsp;Accrued investment income | 0 | 55337 | 0 | 55337 | 55337 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables | 0 | 0 | 24125 | 24125 | 25336 |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 0 | 28532 | 0 | 28532 | 28532 |
| &nbsp;&nbsp;&nbsp;Other assets | 0 | 5819 | 0 | 5819 | 5819 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $203 | $89688 | $1828302 | $1918193 | $1908613 |
| **Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances - investment contracts | $0 | $124201 | $30727 | $154928 | $156140 |
| &nbsp;&nbsp;&nbsp;Payables to parent and affiliates | 0 | 168 | 0 | 168 | 168 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 0 | 80289 | 0 | 80289 | 80289 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | $0 | $204658 | $30727 | $235385 | $236597 |

---

39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Fair Value** | **Fair Value** | **Fair Value** | **Fair Value** | **Carrying<br>Amount(1)** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;Commercial mortgage and other loans | $0 | $0 | $473122 | $473122 | $477328 |
| &nbsp;&nbsp;&nbsp;Policy loans | 0 | 0 | 1118589 | 1118589 | 1118589 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 1000 | 0 | 0 | 1000 | 1000 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 3246 | 0 | 0 | 3246 | 3246 |
| &nbsp;&nbsp;&nbsp;Accrued investment income | 0 | 60368 | 0 | 60368 | 60368 |
| &nbsp;&nbsp;&nbsp;Reinsurance recoverables and deposit receivables | 0 | 0 | 24111 | 24111 | 25915 |
| &nbsp;&nbsp;&nbsp;Receivables from parent and affiliates | 0 | 40630 | 0 | 40630 | 40630 |
| &nbsp;&nbsp;&nbsp;Other assets | 0 | 3396 | 0 | 3396 | 3396 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $4246 | $104394 | $1615822 | $1724462 | $1730472 |
| **Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Policyholders' account balances - investment contracts | $0 | $126224 | $32028 | $158252 | $160056 |
| &nbsp;&nbsp;&nbsp;Payables to parent and affiliates | 0 | 462 | 0 | 462 | 462 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 0 | 67206 | 0 | 67206 | 67206 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | $0 | $193892 | $32028 | $225920 | $227724 |

---

(1)Carrying values presented herein differ from those in the Company's Unaudited Interim Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.

 **6.&nbsp;&nbsp;&nbsp;&nbsp;DEFERRED POLICY ACQUISITION COSTS AND DEFERRED REINSURANCE**

***Deferred Policy Acquisition Costs ("DAC")***

The following tables show a rollforward for the lines of business that contain DAC balances, along with a reconciliation to the Company's total DAC balance:

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Term Life** | **Variable / Universal Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $67323 | $349993 | $417316 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalization | 15400 | 41566 | 56966 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | (3001) | (11427) | (14428) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (53) | 0 | (53) |
| Balance, end of period | $79669 | $380132 | 459801 |
| &nbsp;&nbsp;Other, end of period |  |  | 375 |
| Total balance, end of period |  |  | $460176 |

---

40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Term Life** | **Variable / Universal Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $82008 | $311131 | $393139 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalization | 15514 | 41631 | 57145 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | (5773) | (10800) | (16573) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other(1) | (15) | (2733) | (2748) |
| Balance, end of period | $91734 | $339229 | $430963 |

---

(1)Other includes the impact of the Universal Life reinsurance transaction with Prudential Arizona Reinsurance Universal Company ("PAR U") and PURE. See Note 11 for additional information.

***Deferred Reinsurance Losses ("DRL")***

The following tables show a rollforward for the lines of business that contain DRL balances, along with a reconciliation to the Company's total DRL balance:

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Variable Annuities** | **Term Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $14578 | $50800 | $65378 |
| &nbsp;&nbsp;Amortization expense | (1020) | (3452) | (4472) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 4 | 0 | 4 |
| Balance, end of period | $13562 | $47348 | $60910 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Variable Annuities** | **Term Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $15968 | $0 | $15968 |
| &nbsp;&nbsp;Amortization expense | (1060) | 0 | (1060) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 10 | 0 | 10 |
| Balance, end of period | $14918 | $0 | $14918 |

---

***Deferred Reinsurance Gains ("DRG")***

The following tables show a rollforward of DRG balances for variable and universal life products, which are the only lines of business that contain a DRG balance, along with a reconciliation to the Company's total DRG balance:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **Variable / Universal Life** | **Variable / Universal Life** |
| | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $208644 | $0 |
| &nbsp;&nbsp;Amortization | (6589) | (5959) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other(1) | 0 | 187732 |
| Balance, end of period | $202055 | $181773 |

---

(1)Other includes the impact of the Universal Life reinsurance transaction with PAR U, PURE and Prudential Insurance. See Note 11 for additional information.

41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**7.&nbsp;&nbsp;&nbsp;&nbsp;SEPARATE ACCOUNTS**

The Company issues variable annuity and variable life insurance contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. Most variable annuity and variable life insurance contracts are offered with both separate and general account options. See Note 9 for additional information.

The assets supporting the variable portion of variable annuity and variable life insurance contracts are carried at fair value and reported as "Separate account assets" with an equivalent amount reported as "Separate account liabilities". The liabilities related to the net amount at risk are reflected within "Future policy benefits" or "Market risk benefit liabilities" (or "assets", if applicable). Amounts assessed against the contractholders for mortality, administration, and other services are included within revenue in "Policy charges and fee income" and changes in liabilities for minimum guarantees are generally included in "Policyholders' benefits" or "Change in value of market risk benefits, net of related hedging gains (losses)".

***Separate Account Assets***

The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| **Asset Type:** | | |
| &nbsp;&nbsp;&nbsp;Mutual funds: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $8962445 | $8454468 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 3832647 | 4030334 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 877810 | 767111 |
| &nbsp;&nbsp;&nbsp;Other invested assets | 1342560 | 1255640 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $15015462 | $14507553 |

---

For the nine months ended September 30, 2025 and year ended December 31, 2024, there were no transfers of assets, other than cash, from the general account to a separate account; therefore, no gains or losses were recorded.

***Separate Account Liabilities*** 

The balances of and changes in separate account liabilities as of and for the periods indicated are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Variable Annuities** | **Variable Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $8578627 | $5928926 | $14507553 |
| &nbsp;&nbsp;&nbsp;&nbsp; Deposits | 63442 | 197628 | 261070 |
| &nbsp;&nbsp;&nbsp;&nbsp; Investment performance | 828026 | 681201 | 1509227 |
| &nbsp;&nbsp;&nbsp;&nbsp; Policy charges | (148016) | (86582) | (234598) |
| &nbsp;&nbsp;&nbsp;&nbsp; Surrenders and withdrawals | (868223) | (68023) | (936246) |
| &nbsp;&nbsp;&nbsp;&nbsp; Benefit payments | (3932) | (38824) | (42756) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net transfers (to) from general account | (32609) | (47118) | (79727) |
| &nbsp;&nbsp;&nbsp;&nbsp; Other | 612 | 30327 | 30939 |
| Balance, end of period | $8417927 | $6597535 | $15015462 |
| Cash surrender value(1) | $8338949 | $6470903 | $14809852 |

---

42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Variable Annuities** | **Variable Life** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $9064177 | $5012926 | $14077103 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits | 60136 | 185619 | 245755 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment performance | 958449 | 816250 | 1774699 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy charges | (162183) | (82614) | (244797) |
| &nbsp;&nbsp;&nbsp;&nbsp;Surrenders and withdrawals | (797020) | (48738) | (845758) |
| &nbsp;&nbsp;&nbsp;&nbsp;Benefit payments | (7537) | (30703) | (38240) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net transfers (to) from general account | (19357) | (38011) | (57368) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 479 | 29333 | 29812 |
| Balance, end of period | $9097144 | $5844062 | $14941206 |
| Cash surrender value(1) | $8984658 | $5727288 | $14711946 |

---

(1)Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges.

**8.&nbsp;&nbsp;&nbsp;&nbsp;LIABILITY FOR FUTURE POLICY BENEFITS**

Liability for future policy benefits primarily consists of the following sub-components, which are discussed in greater detail below.

• Benefit reserves;

• Deferred profit liability ("DPL"); and

• Additional insurance reserves ("AIR")

In 2025, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for liability for future policy benefits. The impact was favorable for direct and assumed benefit reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in individual life insurance. Additionally, there was a favorable impact for direct and assumed AIR, primarily due to offsetting impacts from updated policyholder behavior assumptions and mortality assumptions on universal life policies.

In 2024, the Company recognized an impact to net income attributable to our annual reviews and update of assumptions and other refinements for liability for future policy benefits. Overall impact is immaterial for direct and assumed benefit reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort. Additionally, for direct and assumed AIR, the Company recognized an unfavorable impact primarily due to updates to policyholder behavior assumptions on universal life policies with secondary guarantees.

43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Benefit Reserves***

The balances of and changes in benefit reserves as of and for the periods indicated consist of the three tables presented below: present value of expected net premiums rollforward, present value of expected future policy benefits rollforward, and net liability for future policy benefits.

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Present Value of Expected Net Premiums** | **Present Value of Expected Net Premiums** | **Present Value of Expected Net Premiums** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $1287544 | $0 | $1287544 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, beginning of period | 75036 | 0 | 75036 |
| Balance at original discount rate, beginning of period | 1362580 | 0 | 1362580 |
| &nbsp;&nbsp;&nbsp;Effect of assumption update | (24177) | 0 | (24177) |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience and other activity | (24937) | 171 | (24766) |
| Adjusted balance, beginning of period | 1313466 | 171 | 1313637 |
| &nbsp;&nbsp;&nbsp;Issuances | 72688 | 2249 | 74937 |
| &nbsp;&nbsp;&nbsp;Net premiums / considerations collected | (115292) | (2420) | (117712) |
| &nbsp;&nbsp;&nbsp;Interest accrual | 47577 | 0 | 47577 |
| &nbsp;&nbsp;&nbsp;Other adjustments | (7872) | 0 | (7872) |
| Balance at original discount rate, end of period | 1310567 | 0 | 1310567 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, end of period | (34304) | 0 | (34304) |
| Balance, end of period | $1276263 | $0 | $1276263 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Present Value of Expected Future Policy Benefits** | **Present Value of Expected Future Policy Benefits** | **Present Value of Expected Future Policy Benefits** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $2499241 | $20516 | $2519757 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, beginning of period | 164980 | 1477 | 166457 |
| Balance at original discount rate, beginning of period | 2664221 | 21993 | 2686214 |
| &nbsp;&nbsp;&nbsp;Effect of assumption update | (50976) | 0 | (50976) |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience and other activity | (26253) | 295 | (25958) |
| Adjusted balance, beginning of period | 2586992 | 22288 | 2609280 |
| &nbsp;&nbsp;&nbsp;Issuances | 72688 | 2249 | 74937 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 96489 | 655 | 97144 |
| &nbsp;&nbsp;&nbsp;Benefit payments | (121788) | (2262) | (124050) |
| &nbsp;&nbsp;&nbsp;Other adjustments | (6202) | (93) | (6295) |
| Balance at original discount rate, end of period | 2628179 | 22837 | 2651016 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, end of period | (81385) | (1120) | (82505) |
| Balance, end of period | $2546794 | $21717 | $2568511 |

---

44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Net Liability for Future Policy Benefits (Benefit Reserves)** | **Net Liability for Future Policy Benefits (Benefit Reserves)** | **Net Liability for Future Policy Benefits (Benefit Reserves)** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, end of period, pre-flooring | $1270531 | $21717 | $1292248 |
| &nbsp;&nbsp;&nbsp;Flooring impact, end of period | 14 | 0 | 14 |
| Balance, end of period, post-flooring | 1270545 | 21717 | 1292262 |
| &nbsp;&nbsp;&nbsp;Less: Reinsurance recoverables | 1181667 | 21717 | 1203384 |
| Balance after reinsurance recoverables, end of period, post-flooring | $88878 | $0 | $88878 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Present Value of Expected Net Premiums** | **Present Value of Expected Net Premiums** | **Present Value of Expected Net Premiums** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $1389421 | $0 | $1389421 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, beginning of period | 29313 | 0 | 29313 |
| Balance at original discount rate, beginning of period | 1418734 | 0 | 1418734 |
| &nbsp;&nbsp;&nbsp;Effect of assumption update | 9001 | 0 | 9001 |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience and other activity | (50258) | (208) | (50466) |
| Adjusted balance, beginning of period | 1377477 | (208) | 1377269 |
| &nbsp;&nbsp;&nbsp;Issuances | 73754 | 3124 | 76878 |
| &nbsp;&nbsp;&nbsp;Net premiums / considerations collected | (118830) | (2916) | (121746) |
| &nbsp;&nbsp;&nbsp;Interest accrual | 48583 | 0 | 48583 |
| Balance at original discount rate, end of period | 1380984 | 0 | 1380984 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, end of period | (15631) | 0 | (15631) |
| Balance, end of period | $1365353 | $0 | $1365353 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Present Value of Expected Future Policy Benefits** | **Present Value of Expected Future Policy Benefits** | **Present Value of Expected Future Policy Benefits** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $2619569 | $18489 | $2638058 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, beginning of period | 44322 | 1510 | 45832 |
| Balance at original discount rate, beginning of period | 2663891 | 19999 | 2683890 |
| &nbsp;&nbsp;&nbsp;Effect of assumption update | 10368 | (241) | 10127 |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience and other activity | (69283) | 106 | (69177) |
| Adjusted balance, beginning of period | 2604976 | 19864 | 2624840 |
| &nbsp;&nbsp;&nbsp;Issuances | 73754 | 3124 | 76878 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 96145 | 560 | 96705 |
| &nbsp;&nbsp;&nbsp;Benefit payments | (109055) | (1998) | (111053) |
| &nbsp;&nbsp;&nbsp;Other adjustments | (215) | 2 | (213) |
| Balance at original discount rate, end of period | 2665605 | 21552 | 2687157 |
| &nbsp;&nbsp;&nbsp;Effect of cumulative changes in discount rate assumptions, end of period | (22362) | (1091) | (23453) |
| Balance, end of period | $2643243 | $20461 | $2663704 |

---

45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Net Liability for Future Policy Benefits (Benefit Reserves)** | **Net Liability for Future Policy Benefits (Benefit Reserves)** | **Net Liability for Future Policy Benefits (Benefit Reserves)** |
| | **Term Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, end of period, pre-flooring | $1277890 | $20461 | $1298351 |
| &nbsp;&nbsp;&nbsp;Flooring impact, end of period | 14 | 0 | 14 |
| Balance, end of period, post-flooring | 1277904 | 20461 | 1298365 |
| &nbsp;&nbsp;&nbsp;Less: Reinsurance recoverables | 1087466 | 20461 | 1107927 |
| Balance after reinsurance recoverables, end of period, post-flooring | $190438 | $0 | $190438 |

---

The following tables provide supplemental information related to the balances of and changes in benefit reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Term Life** | **Term Life** | **Fixed Annuities** | **Fixed Annuities** |
| | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Undiscounted expected future gross premiums | $3005380 | 3005380 | $0 | 0 |
| Discounted expected future gross premiums (at original discount rate) | $1984926 | 1984926 | $0 | 0 |
| Discounted expected future gross premiums (at current discount rate) | $1944542 | 1944542 | $0 | 0 |
| Undiscounted expected future benefits and expenses | $4245670 | 4245670 | $30433 | 30433 |
| Weighted-average duration of the liability in years (at original discount rate) | 10 | 10 | 6 | 6 |
| Weighted-average duration of the liability in years (at current discount rate) | 9 | 9 | 5 | 5 |
| Weighted-average interest rate (at original discount rate) | 5.19 | % | 4.16 | % |
| Weighted-average interest rate (at current discount rate) | 5.22 | % | 4.97 | % |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Term Life** | **Term Life** | **Fixed Annuities** | **Fixed Annuities** |
| | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Undiscounted expected future gross premiums | $3014568 | 3014568 | $0 | 0 |
| Discounted expected future gross premiums (at original discount rate) | $2009087 | 2009087 | $0 | 0 |
| Discounted expected future gross premiums (at current discount rate) | $1995991 | 1995991 | $0 | 0 |
| Undiscounted expected future benefits and expenses | $4312461 | 4312461 | $27898 | 27898 |
| Weighted-average duration of the liability in years (at original discount rate) | 10 | 10 | 6 | 6 |
| Weighted-average duration of the liability in years (at current discount rate) | 10 | 10 | 5 | 5 |
| Weighted-average interest rate (at original discount rate) | 5.23 | % | 3.92 | % |
| Weighted-average interest rate (at current discount rate) | 4.93 | % | 4.72 | % |

---

For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2 to the Company's Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.

For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss, respectively.

46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

In the first nine months of 2025, there was a $2 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, offset by a $2 million gain, reflecting the impact of ceded reinsurance on the affected cohorts.

In the first nine months of 2024, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts.

***Deferred Profit Liability***

The balances of and changes in DPL as of and for the periods indicated are as follows:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **Fixed Annuities** | **Fixed Annuities** |
| | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period, post flooring | $1513 | $1365 |
| &nbsp;&nbsp;&nbsp;Effect of assumption update | 0 | 106 |
| &nbsp;&nbsp;&nbsp;Effect of actual variances from expected experience and other activity | (5) | (223) |
| Adjusted balance, beginning of period | 1508 | 1248 |
| &nbsp;&nbsp;&nbsp;Profits deferred | 907 | 364 |
| &nbsp;&nbsp;&nbsp;Interest accrual | 66 | 39 |
| &nbsp;&nbsp;&nbsp;Amortization | (204) | (148) |
| &nbsp;&nbsp;&nbsp;Other adjustments | (4) | 1 |
| Balance, end of period, post-flooring | 2273 | 1504 |
| &nbsp;&nbsp;&nbsp;Less: Reinsurance recoverables | 2273 | 1504 |
| Balance after reinsurance recoverables, end of period | $0 | $0 |

---

47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Additional Insurance Reserves***

AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts.

The following table shows a rollforward of AIR balances for variable and universal life products for the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** |
| Balance including amounts in AOCI, beginning of period, post-flooring | $1134475 | $986166 |
| &nbsp;&nbsp;Flooring impact and amounts in AOCI | 32954 | 56487 |
| Balance, excluding amounts in AOCI, beginning of period, pre-flooring | 1167429 | 1042653 |
| &nbsp;&nbsp;Effect of assumption update | (1821) | 14446 |
| &nbsp;&nbsp;Effect of actual variances from expected experience and other activity | 15307 | (6321) |
| Adjusted balance, beginning of period | 1180915 | 1050778 |
| &nbsp;&nbsp;Assessments collected(1) | 70705 | 74069 |
| &nbsp;&nbsp;Interest accrual | 30446 | 27463 |
| &nbsp;&nbsp;Benefits paid | (13628) | (15059) |
| Balance, excluding amounts in AOCI, end of period, pre-flooring | 1268438 | 1137251 |
| &nbsp;&nbsp;Flooring impact and amounts in AOCI | (26985) | (16618) |
| Balance, including amounts in AOCI, end of period, post-flooring | 1241453 | 1120633 |
| &nbsp;&nbsp;Less: Reinsurance recoverables | 1207872 | 1088124 |
| Balance after reinsurance recoverables, including amounts in AOCI, end of period | $33581 | $32509 |

---

(1)Represents the portion of gross assessments required to fund the future policy benefits.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| Weighted-average duration of the liability in years (at original discount rate) | 26 | 26 | 27 | 27 |
| Weighted-average interest rate (at original discount rate) | 3.36 | % | 3.41 | % |

---

***Future Policy Benefits Reconciliation***

The following table presents the reconciliation of the ending balances from the above rollforwards, benefit reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for future policy benefits as reported on the Company's Unaudited Interim Statements of Financial Position as of the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** |
| Benefit reserves, end of period, post-flooring | $1292262 | $1298365 |
| Deferred profit liability, end of period, post-flooring | 2273 | 1504 |
| Additional insurance reserves, including amounts in AOCI, end of period, post-flooring | 1241453 | 1120633 |
| &nbsp;&nbsp;Subtotal of amounts disclosed above | 2535988 | 2420502 |
| Other Future policy benefits reserves(1) | 167444 | 166702 |
| &nbsp;&nbsp;Total Future policy benefits | $2703432 | $2587204 |

---

(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities.

48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Revenue and Interest Expense***

The following tables present revenue and interest expense related to benefit reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Statement of Operations for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Revenues(1)** | **Revenues(1)** | **Revenues(1)** | **Revenues(1)** |
| | **Term Life** | **Variable/Universal Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Benefit reserves | $177950 | $0 | $3349 | $181299 |
| Deferred profit liability | 0 | 0 | (760) | (760) |
| Additional insurance reserves | 0 | 163902 | 0 | 163902 |
| Total | $177950 | $163902 | $2589 | $344441 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Revenues(1)** | **Revenues(1)** | **Revenues(1)** | **Revenues(1)** |
| | **Term Life** | **Variable/Universal Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Benefit reserves | $177320 | $0 | $3299 | $180619 |
| Deferred profit liability | 0 | 0 | (139) | (139) |
| Additional insurance reserves | 0 | 189339 | 0 | 189339 |
| Total | $177320 | $189339 | $3160 | $369819 |

---

(1)Represents gross premiums for benefit reserves; revenue for DPL and gross assessments for AIR.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Interest Expense** | **Interest Expense** | **Interest Expense** | **Interest Expense** |
| | **Term Life** | **Variable/Universal Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Benefit reserves | $48912 | $0 | $655 | $49567 |
| Deferred profit liability | 0 | 0 | 66 | 66 |
| Additional insurance reserves | 0 | 30446 | 0 | 30446 |
| Total | $48912 | $30446 | $721 | $80079 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Interest Expense** | **Interest Expense** | **Interest Expense** | **Interest Expense** |
| | **Term Life** | **Variable/Universal Life** | **Fixed Annuities** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Benefit reserves | $47561 | $0 | $560 | $48121 |
| Deferred profit liability | 0 | 0 | 39 | 39 |
| Additional insurance reserves | 0 | 27463 | 0 | 27463 |
| Total | $47561 | $27463 | $599 | $75623 |

---

49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**9.&nbsp;&nbsp;&nbsp;&nbsp;POLICYHOLDERS' ACCOUNT BALANCES**

The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Fixed Annuities** | **Fixed Annuities** | **Variable Annuities** | **Variable Annuities** | **Variable Life / Universal Life** | **Variable Life / Universal Life** | **Total** | **Total** |
| | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Balance, beginning of period | $36453 | 36453 | $1370563 | 1370563 | $3088104 | 3088104 | $4495120 | 4495120 |
| &nbsp;&nbsp;&nbsp;Deposits | 3301 | 3301 | 548620 | 548620 | 193433 | 193433 | 745354 | 745354 |
| &nbsp;&nbsp;&nbsp;Interest credited | 768 | 768 | 35869 | 35869 | 27590 | 27590 | 64227 | 64227 |
| &nbsp;&nbsp;&nbsp;Policy charges | (35) | (35) | (297) | (297) | (108790) | (108790) | (109122) | (109122) |
| &nbsp;&nbsp;&nbsp;Surrenders and withdrawals | (4897) | (4897) | (39896) | (39896) | (125261) | (125261) | (170054) | (170054) |
| &nbsp;&nbsp;&nbsp;Benefit payments | (1136) | (1136) | (2317) | (2317) | (15382) | (15382) | (18835) | (18835) |
| &nbsp;&nbsp;&nbsp;Net transfers (to) from separate account | 0 | 0 | 32609 | 32609 | 47118 | 47118 | 79727 | 79727 |
| &nbsp;&nbsp;&nbsp;Change in market value and other adjustments(1) | 0 | 0 | 145658 | 145658 | 52277 | 52277 | 197935 | 197935 |
| Balance, end of period | $34454 | 34454 | $2090809 | 2090809 | $3159089 | 3159089 | 5284352 | 5284352 |
| Unearned revenue reserve |  |  |  |  |  |  | 461226 | 461226 |
| Other |  |  |  |  |  |  | 10229 | 10229 |
| Total Policyholders' account balance |  |  |  |  |  |  | $5755807 | 5755807 |
| Weighted-average crediting rate | 2.89 | % | 2.76 | % | 1.18 | % | 1.75 | % |
| Net amount at risk(2) | $0 | 0 | $0 | 0 | $36251505 | 36251505 | $36251505 | 36251505 |
| Cash surrender value(3) | $6567 | 6567 | $2023251 | 2023251 | $2817662 | 2817662 | $4847480 | 4847480 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Fixed Annuities** | **Fixed Annuities** | **Variable Annuities** | **Variable Annuities** | **Variable Life / Universal Life** | **Variable Life / Universal Life** | **Total** | **Total** |
| | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** | **($ in thousands)** |
| Balance, beginning of period | $35025 | 35025 | $592581 | 592581 | $3028746 | 3028746 | $3656352 | 3656352 |
| &nbsp;&nbsp;&nbsp;Deposits | 5456 | 5456 | 459924 | 459924 | 166096 | 166096 | 631476 | 631476 |
| &nbsp;&nbsp;&nbsp;Interest credited | 765 | 765 | 16126 | 16126 | 47476 | 47476 | 64367 | 64367 |
| &nbsp;&nbsp;&nbsp;Policy charges | (40) | (40) | (172) | (172) | (110124) | (110124) | (110336) | (110336) |
| &nbsp;&nbsp;&nbsp;Surrenders and withdrawals | (4827) | (4827) | (29403) | (29403) | (108291) | (108291) | (142521) | (142521) |
| &nbsp;&nbsp;&nbsp;Benefit payments | (721) | (721) | (2951) | (2951) | (338) | (338) | (4010) | (4010) |
| &nbsp;&nbsp;&nbsp;Net transfers (to) from separate account | 0 | 0 | 19357 | 19357 | 38011 | 38011 | 57368 | 57368 |
| &nbsp;&nbsp;&nbsp;Change in market value and other adjustments(1) | 0 | 0 | 55577 | 55577 | 15342 | 15342 | 70919 | 70919 |
| Balance, end of period | $35658 | 35658 | $1111039 | 1111039 | $3076918 | 3076918 | 4223615 | 4223615 |
| Unearned revenue reserve |  |  |  |  |  |  | 410876 | 410876 |
| Other |  |  |  |  |  |  | 9865 | 9865 |
| Total Policyholders' account balance |  |  |  |  |  |  | $4644356 | 4644356 |
| Weighted-average crediting rate | 2.89 | % | 2.52 | % | 2.07 | % | 2.18 | % |
| Net amount at risk(2) | $0 | 0 | $0 | 0 | $35095242 | 35095242 | $35095242 | 35095242 |
| Cash surrender value(3) | $8102 | 8102 | $1089086 | 1089086 | $2749470 | 2749470 | $3846658 | 3846658 |

---

(1)Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products.

(2)The net amount at risk calculation includes both general and separate account balances.&nbsp;&nbsp;&nbsp;&nbsp;

(3)Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges.

50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The Company issues variable life and universal life insurance contracts which may also include a "no-lapse guarantee" where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the "no-lapse guarantee" premium is paid.

The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company's primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns.

The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 10 for additional information, including the net amount at risk associated with these guarantees.

The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points ("bps"), between rates being credited to policyholders and the respective guaranteed minimums are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>**Range of Guaranteed Minimum Crediting Rate(1)** | **At guaranteed minimum** | **1 -50 bps above guaranteed minimum** | **51 - 150 bps above guaranteed minimum** | **Greater than 150 bps above guaranteed minimum** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed Annuities** | | | | | |
| &nbsp;&nbsp;Less than 1.00% | $0 | $0 | $0 | $0 | $0 |
| &nbsp;&nbsp;1.00% - 1.99% | 635 | 0 | 0 | 0 | 635 |
| &nbsp;&nbsp;2.00% - 2.99% | 21252 | 0 | 0 | 0 | 21252 |
| &nbsp;&nbsp;3.00% - 4.00% | 5967 | 0 | 0 | 0 | 5967 |
| &nbsp;&nbsp;Greater than 4.00% | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $27854 | $0 | $0 | $0 | $27854 |
| **Variable Annuities** |  |  |  |  |  |
| &nbsp;&nbsp;Less than 1.00% | $3573 | $0 | $0 | $0 | $3573 |
| &nbsp;&nbsp;1.00% - 1.99% | 72076 | 70228 | 0 | 0 | 142304 |
| &nbsp;&nbsp;2.00% - 2.99% | 1430 | 3 | 0 | 0 | 1433 |
| &nbsp;&nbsp;3.00% - 4.00% | 85518 | 0 | 0 | 0 | 85518 |
| &nbsp;&nbsp;Greater than 4.00% | 109 | 0 | 0 | 0 | 109 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $162706 | $70231 | $0 | $0 | $232937 |
| **Variable Life / Universal Life** |  |  |  |  |  |
| &nbsp;&nbsp;Less than 1.00% | $0 | $0 | $0 | $34604 | $34604 |
| &nbsp;&nbsp;1.00% - 1.99% | 38415 | 0 | 311943 | 215304 | 565662 |
| &nbsp;&nbsp;2.00% - 2.99% | 4895 | 170821 | 176808 | 46218 | 398742 |
| &nbsp;&nbsp;3.00% - 4.00% | 309845 | 164069 | 907824 | 0 | 1381738 |
| &nbsp;&nbsp;Greater than 4.00% | 354751 | 0 | 0 | 0 | 354751 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $707906 | $334890 | $1396575 | $296126 | $2735497 |

---

51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
|<br>**Range of Guaranteed Minimum Crediting Rate(1)** | **At guaranteed minimum** | **1 - 50 bps above guaranteed minimum** | **51 - 150 bps above guaranteed minimum** | **Greater than 150 bps above guaranteed minimum** | **Total** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Fixed Annuities** | | | | | |
| &nbsp;&nbsp;Less than 1.00% | $0 | $0 | $0 | $0 | $0 |
| &nbsp;&nbsp;1.00% - 1.99% | 893 | 0 | 0 | 0 | 893 |
| &nbsp;&nbsp;2.00% - 2.99% | 20130 | 0 | 0 | 0 | 20130 |
| &nbsp;&nbsp;3.00% - 4.00% | 7367 | 0 | 0 | 0 | 7367 |
| &nbsp;&nbsp;Greater than 4.00% | 0 | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $28390 | $0 | $0 | $0 | $28390 |
| **Variable Annuities** |  |  |  |  |  |
| &nbsp;&nbsp;Less than 1.00% | $2951 | $0 | $0 | $0 | $2951 |
| &nbsp;&nbsp;1.00% - 1.99% | 114191 | 50620 | 1534 | 0 | 166345 |
| &nbsp;&nbsp;2.00% - 2.99% | 1279 | 2 | 0 | 0 | 1281 |
| &nbsp;&nbsp;3.00% - 4.00% | 99705 | 861 | 0 | 0 | 100566 |
| &nbsp;&nbsp;Greater than 4.00% | 134 | 0 | 0 | 0 | 134 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $218260 | $51483 | $1534 | $0 | $271277 |
| **Variable Life / Universal Life** |  |  |  |  |  |
| &nbsp;&nbsp;Less than 1.00% | $0 | $0 | $0 | $24484 | $24484 |
| &nbsp;&nbsp;1.00% - 1.99% | 27959 | 0 | 285234 | 207376 | 520569 |
| &nbsp;&nbsp;2.00% - 2.99% | 4264 | 162137 | 174910 | 42874 | 384185 |
| &nbsp;&nbsp;3.00% - 4.00% | 252340 | 235856 | 915873 | 0 | 1404069 |
| &nbsp;&nbsp;Greater than 4.00% | 365918 | 0 | 0 | 0 | 365918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $650481 | $397993 | $1376017 | $274734 | $2699225 |

---

(1)Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options.

**Unearned Revenue Reserve ("URR")**

The balances of and changes in URR as of and for the periods ended are as follows:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | **Variable Life / Universal Life** | **Variable Life / Universal Life** |
| | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $423240 | $370258 |
| &nbsp;&nbsp;Unearned revenue | 52294 | 54039 |
| &nbsp;&nbsp;Amortization expense | (14308) | (13421) |
| Balance, end of period | $461226 | $410876 |

---

52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**10.&nbsp;&nbsp;&nbsp;&nbsp;MARKET RISK BENEFITS**

The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company's total net MRB positions as of the following dates:

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Variable Annuities** | **Less: Reinsured Market Risk Benefits** | **Total, Net of Reinsurance** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $190687 | $(190687) | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of cumulative changes in non-performance risk | 61123 | 0 | 61123 |
| Balance, beginning of period, before effect of changes in non-performance risk | 251810 | (190687) | 61123 |
| &nbsp;&nbsp;&nbsp;&nbsp;Attributed fees collected | 71031 | (71031) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Claims paid | (1384) | 1384 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest accrual | 10852 | (10852) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Actual in force different from expected | 4618 | (4618) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in interest rates | 10495 | (10495) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in equity markets | (91963) | 91963 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of assumption update and other refinements | 13514 | (13514) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuances | 4898 | (4898) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other adjustments | 2052 | (2052) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in current period counterparty non-performance risk | 0 | (6672) | (6672) |
| Balance, end of period, before effect of changes in non-performance risk | 275923 | (221472) | 54451 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of cumulative changes in non-performance risk | (54451) | 0 | (54451) |
| Balance, end of period | $221472 | $(221472) | $0 |

---

53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Variable Annuities** | **Less: Reinsured Market Risk Benefits** | **Total, Net of Reinsurance** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, beginning of period | $301771 | $(301771) | $0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of cumulative changes in non-performance risk | 100377 | 0 | 100377 |
| Balance, beginning of period, before effect of changes in non-performance risk | 402148 | (301771) | 100377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Attributed fees collected | 77254 | (77254) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Claims paid | (1860) | 1860 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest accrual | 14294 | (14294) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Actual in force different from expected | (405) | 405 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in interest rates | 1642 | (1642) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in equity markets | (143284) | 143284 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of assumption update and other refinements(1) | 6091 | (6091) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuances | 3228 | (3228) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other adjustments(1) | 600 | (600) | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of changes in current period counterparty non-performance risk | 0 | (10520) | (10520) |
| Balance, end of period, before effect of changes in non-performance risk | 359708 | (269851) | 89857 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of cumulative changes in non-performance risk | (89857) | 0 | (89857) |
| Balance, end of period | $269851 | $(269851) | $0 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Prior period amounts have been updated to conform to current presentation.

In both 2025 and 2024, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions.

The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods.

The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death.

For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company's primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality.

For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company's primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality.

For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance.

54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company's primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior.

The following table presents accompanying information to the rollforward table above.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2024** |
| | **Variable Annuities** | **Variable Annuities** |
| | **($ in thousands)** | **($ in thousands)** |
| Net amount at risk(1) | $625447 | $582042 |
| Weighted-average attained age of contractholders | 71 | 70 |

---

(1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included.

The table below reconciles MRB asset and liability positions as of the following dates:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2024** |
| | **Variable Annuities** | **Variable Annuities** |
| | **(in thousands)** | **(in thousands)** |
| Direct and assumed | $137640 | $128830 |
| Ceded | 359111 | 398681 |
| &nbsp;&nbsp;Total market risk benefit assets | $496751 | $527511 |
| Direct and assumed | $359111 | $398681 |
| Ceded | 137640 | 128830 |
| &nbsp;&nbsp;Total market risk benefit liabilities | $496751 | $527511 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net balance | $0 | $0 |

---

**11.&nbsp;&nbsp;&nbsp;&nbsp;REINSURANCE**

The Company participates in reinsurance with its affiliates Prudential Arizona Reinsurance Captive Company ("PARCC"), PAR U, PURE, its parent companies, Pruco Life and Prudential Insurance, and prior to October 1, 2024 with its affiliates Prudential Arizona Reinsurance Term Company ("PAR Term"), Prudential Term Reinsurance Company ("Term Re") and Dryden Arizona Reinsurance Term Company ("DART"). The Company also participates in reinsurance with third-parties. The reinsurance agreements provide risk diversification and additional capacity for future growth, limit the maximum net loss potential, manage statutory capital, and facilitate the Company's capital market hedging program. Life reinsurance is accomplished through various plans of reinsurance, primarily yearly renewable term ("YRT") and coinsurance. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. The Company believes a material reinsurance liability resulting from such inability of reinsurers to meet their obligations is unlikely.

Effective January 2024, the Company entered into an agreement with Somerset Reinsurance Ltd. ("Somerset Re") to coinsure a closed block of guaranteed universal life ("GUL") policies to PURE, a wholly-owned subsidiary of Prudential Insurance, with retrocession by PURE of such liabilities on a modified coinsurance basis, to Somerset Re. This transaction is effective as of January 1, 2024, whereby, the Company recaptured all risks associated with the subject GUL policies from PAR U and subsequently established YRT reinsurance for the subject GUL business with Prudential Insurance. As a result of these transactions, the Company recognized a $173 million pre-tax recapture loss and a $188 million DRG, respectively. The DRG will be amortized into income over the estimated remaining life of the reinsured policies.

55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

Reserves related to reinsured long-duration contracts are accounted for using assumptions consistent with those used to account for the underlying contracts. Amounts recoverable from reinsurers for long-duration reinsurance arrangements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Reinsurance policy charges and fee income ceded for universal life and variable annuity products are accounted for as a reduction of policy charges and fee income. Reinsurance premiums ceded for term insurance products are accounted for as a reduction of premiums.

"Change in value of market risk benefits, net of related hedging gains (losses)" includes the impact of reinsurance agreements, particularly reinsurance agreements involving living benefit guarantees. The Company has entered into a reinsurance agreement to transfer the risk related to living benefit guarantees on variable annuities to Prudential Insurance. These reinsurance agreements are MRBs and have been accounted for in the same manner.

Reinsurance amounts included in the Company's Unaudited Interim Statements of Financial Position were as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| Reinsurance recoverables and deposit receivables | $5687885 | $4929428 |
| Policy loans | (34261) | (32760) |
| Deferred policy acquisition costs | (640728) | (647934) |
| Deferred sales inducements | (30803) | (32573) |
| Market risk benefit assets | 359111 | 341565 |
| Other assets | 66441 | 70934 |
| Market risk benefit liabilities | 137640 | 150878 |
| Reinsurance payables | 2079148 | 1440264 |
| Other liabilities | 202056 | 208543 |

---

Reinsurance recoverables and deposit receivables by counterparty were as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| | **(in thousands)** | **(in thousands)** |
| Prudential Insurance | $2405572 | $1856410 |
| PARCC | 1209839 | 1173578 |
| Pruco Life | 1053442 | 914840 |
| PURE | 1011928 | 981917 |
| PAR U | 0 | 380 |
| Unaffiliated | 7104 | 2303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total reinsurance recoverables and deposit receivables | $5687885 | $4929428 |

---

56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

Reinsurance amounts, included in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss) were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Premiums:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $57840 | $60029 | $178436 | $180147 |
| &nbsp;&nbsp;Ceded | (46317) | (48318) | (144229) | (145950) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums | $11523 | $11711 | $34207 | $34197 |
| **Policy charges and fee income:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $94972 | $96670 | $277253 | $279173 |
| &nbsp;&nbsp;Assumed | 5582 | 9022 | 13810 | 44737 |
| &nbsp;&nbsp;Ceded(1) | (73247) | (84619) | (221777) | 51780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net policy charges and fee income | $27307 | $21073 | $69286 | $375690 |
| **Net investment income:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $70298 | $57265 | $194188 | $159685 |
| &nbsp;&nbsp;Ceded | (325) | (268) | (961) | (867) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | $69973 | $56997 | $193227 | $158818 |
| **Asset administration fees:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $9591 | $9642 | $27870 | $28021 |
| &nbsp;&nbsp;Ceded | (6236) | (6705) | (18428) | (19845) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net asset administration fees | $3355 | $2937 | $9442 | $8176 |
| **Other income (loss):** |  |  |  |  |
| &nbsp;&nbsp;Direct | $1522 | $2213 | $4498 | $2307 |
| &nbsp;&nbsp;Ceded | 1650 | 1964 | 4968 | 6021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net other income (loss) | $3172 | $4177 | $9466 | $8328 |
| **Realized investment gains (losses), net:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $(17331) | $(23527) | $(94434) | $(9323) |
| &nbsp;&nbsp;Ceded | (23440) | (13163) | (61500) | (38965) |
| &nbsp;&nbsp;&nbsp;&nbsp;Realized investment gains (losses), net | $(40771) | $(36690) | $(155934) | $(48288) |
| **Change in value of market risk benefits, net of related hedging gains (losses):** |  |  |  |  |
| &nbsp;&nbsp;Direct | $66328 | $(39273) | $51312 | $119558 |
| &nbsp;&nbsp;Ceded | (45064) | 33940 | (44640) | (109038) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in value of market risk benefits, net of related hedging gains (losses) | $21264 | $(5333) | $6672 | $10520 |
| **Policyholders' benefits (including change in reserves):** |  |  |  |  |
| &nbsp;&nbsp;Direct | $116466 | $85234 | $376530 | $307749 |
| &nbsp;&nbsp;Assumed | 0 | 0 | 42 | 508 |
| &nbsp;&nbsp;Ceded(2) | (108475) | (88782) | (321337) | 255842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net policyholders' benefits (including change in reserves) | $7991 | $(3548) | $55235 | $564099 |
| **Change in estimates of liability for future policy benefits:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $2370 | $11683 | $(24775) | $31021 |
| &nbsp;&nbsp;Ceded | 901 | (12723) | 7774 | (36245) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in estimates of liability for future policy benefits | $3271 | $(1040) | $(17001) | $(5224) |

---

57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| **Interest credited to policyholders' account balances:** |  |  |  |  |
| &nbsp;&nbsp;Direct | $41926 | $34328 | $97561 | $98038 |
| &nbsp;&nbsp;Ceded | (20112) | (15116) | (57596) | (37628) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net interest credited to policyholders' account balances | $21814 | $19212 | $39965 | $60410 |
| **Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization** | $(30418) | $(29702) | $(90170) | $(123367) |

---

(1)Includes $(1.4) million and $(1.3) million of unaffiliated activity for the three months ended September 30, 2025 and 2024, respectively, and $(4.0) million and $(3.8) million for the nine months ended September 30, 2025 and 2024, respectively.

(2)Includes $(2.2) million and $0.0 million of unaffiliated activity for the three months ended September 30, 2025 and 2024, respectively, and $(3.3) million and $(2.3) million for the nine months ended September 30, 2025 and 2024, respectively.

The gross and net amounts of life insurance face amount in force were as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2024** |
| | **(in thousands)** | **(in thousands)** |
| Direct gross life insurance face amount in force | $158586995 | $156027156 |
| Reinsurance ceded | (148932605) | (142591118) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net life insurance face amount in force | $9654390 | $13436038 |

---

***Significant Affiliated Reinsurance Agreements***

**Prudential Insurance**

The Company has a YRT reinsurance agreement with Prudential Insurance and reinsures the majority of all mortality risks not otherwise reinsured. Effective July 1, 2017, this agreement was terminated for certain new business, primarily universal life business, and such business was reinsured to Pruco Life under a YRT reinsurance agreement. As of January 1, 2020, the remaining portions of new business (specifically term policies) ceased being reinsured by the Company to Prudential Insurance, and a separate YRT reinsurance agreement was established with Pruco Life for term policies. Effective January 1, 2024, the Company recaptured all GUL policies with Prudential Insurance and subsequently entered into a YRT reinsurance agreement with Prudential Insurance to reinsure the mortality risk for the totality of GUL policies reinsured to PURE. Effective October 1, 2024, the Company recaptured the term business from Prudential Insurance in which the policies are ceded to PARCC. As a result of the recapture, the Company recognized a $6 million pre-tax recapture loss.

Effective April 1, 2016, the Company entered into a reinsurance agreement with Prudential Insurance to reinsure its variable annuity base contracts, along with the living benefit guarantees. As of December 31, 2020, the Company discontinued the sales of traditional variable annuities guaranteed living benefit riders. This discontinuation has no impact on the reinsurance agreement between Prudential Insurance and the Company. Effective February 1, 2023, the Company began selling indexed variable annuities products, which is reinsured to Prudential Insurance through the existing reinsurance agreement. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts to Prudential Insurance. As a result of the agreement, reinsurance payables includes the ceded modified coinsurance arrangement, which reflects the value of the invested assets retained by the Company and the associated asset returns.

**PAR U**

Effective July 1, 2012, the Company reinsures 95% of all risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates through December 31, 2019, excluding those policies that are subject to principle-based reserving.

58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

Effective January 1, 2024, the Company recaptured the policies previously reinsured by PAR U with effective dates prior to January 1, 2015. Effective January 1, 2024, the Company reinsures 100% of the risks associated with universal life policies with effective dates from January 1, 2015 to December 31, 2019.

Effective October 1, 2024, the Company recaptured 100% of the risks associated with the remaining universal life policies with effective dates from January 1, 2015 to December 31, 2019. As a result of the recapture, the Company recognized a $29 million pre-tax recapture loss, which includes the recognition of a prior $8 million DRG related to the previous reinsurance agreement. Following the result of this recapture, PLNJ no longer cedes to PAR U as of December 31, 2024.

**PURE** 

Effective January 1, 2024, the Company reinsures 100% of the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies with effective dates prior to January 1, 2015.

**PARCC**

The Company reinsures 90% of the risks under its term life insurance policies, with effective dates prior to January 1, 2010 through an automatic coinsurance agreement with PARCC.

Effective October 1, 2024, the Company revised the existing coinsurance terms with PARCC, increasing the quota share of reinsured policies to 100% which includes policies which were previously reinsured to PAR Term, Term Re and DART. As a result of the revised terms, the Company recognized a $52 million DRL that will be amortized into income over the estimated remaining life of the reinsured policies.

On November 20, 2024, PAR Term, Term Re and DART merged into PARCC.

**PAR Term**

The Company reinsures 95% of the risks under its term life insurance policies, with effective dates January 1, 2010 through December 31, 2013, through an automatic coinsurance agreement with PAR Term.

On November 20, 2024, PAR Term merged into PARCC.

**Term Re**

The Company reinsures 95% of the risks under its term life insurance policies, with effective dates on or after January 1, 2014 through December 31, 2017, through an automatic coinsurance agreement with Term Re.

On November 20, 2024, Term Re merged into PARCC.

**Pruco Life**

Effective July 1, 2017, the Company entered into a YRT reinsurance agreement with Pruco Life for new business, primarily covering universal life policies. Effective January 1, 2020, the Company entered in a similar YRT reinsurance agreement with Pruco Life for new business relating to term policies. Under these agreements the majority of all mortality risk is ceded to Pruco Life. The Company also reinsures certain Corporate Owned Life Insurance ("COLI") policies with Pruco Life. Through March 31, 2016, the Company reinsured Prudential Defined Income ("PDI") living benefit guarantees with Pruco Life. Effective April 1, 2016, the Company recaptured PDI living benefit guarantees from Pruco Life and reinsured them, together with the related variable annuity base contracts, with Prudential Insurance.

Effective October 1, 2024, the Company entered into an agreement with Pruco Life to reinsure the Universal Protector policies having no-lapse guarantees as well as certain other universal life policies with effective dates from January 1, 2015 to December 31, 2019, that were previously reinsured to PAR U. As a result of the transaction, the Company recognized a $37 million DRG that will be amortized into income over the estimated remaining life of the reinsured policies.

**DART**

Effective January 1, 2018, the Company entered into an automatic coinsurance agreement with DART to reinsure 95% of the risks associated with its term life insurance policies with effective dates on or after January 1, 2018 through December 31, 2019, excluding those policies that are subject to principle-based reserving.

On November 20, 2024, DART merged into PARCC.

59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**12.&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES**

The Company uses a full year projected effective tax rate approach to calculate year-to-date taxes. In determining the full year projected tax rate, the Company considers the realizability of deferred tax assets, including those associated with unrealized investment losses, and has determined based upon the weight of available evidence that no valuation allowance is necessary related to unrealized investment losses. In addition, certain items impacting total income tax expense are recorded in the periods in which they occur. The projected effective tax rate is the ratio of projected "Income tax expense (benefit)" divided by projected "Income (loss) from operations before income taxes". The interim period tax expense (or benefit) is the difference between the year-to-date income tax provision and the amounts reported for the previous interim periods of the fiscal year.

The Company's income tax provision amounted to an income tax expense of $3.1 million, or 8.83% of income (loss) from operations before income taxes in the first nine months of 2025, compared to an income tax benefit of $(31.2) million, or 34.43%, in the first nine months of 2024. The Company's current and prior effective tax rates differed from the U.S. statutory tax rate of 21% primarily due to non-taxable investment income and tax credits.

*<u>Tax Law Change.</u>* H.R.1, also referred to as the "One Big Beautiful Bill Act" (the "Tax Act of 2025"), was enacted into law on July 4, 2025. While the Company is currently evaluating the impact of the Tax Act of 2025 on its future financial statements and related disclosures, the Company does not anticipate that the provisions of the Tax Act of 2025 will have a material impact on its effective tax rate and deferred tax positions beginning in the third quarter of 2025.

**13.&nbsp;&nbsp;&nbsp;&nbsp;EQUITY**

***Accumulated Other Comprehensive Income (Loss)***

AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Unaudited Interim Statements of Operations and Comprehensive Income (Loss). The balance of and changes in each component of AOCI as of and for the nine months ended September 30, 2025 and 2024, are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** |
| | **Foreign Currency Translation Adjustment** | **Net Unrealized Investment Gains (Losses)(1)** | **Interest Rate Remeasurement of Future Policy Benefits** | **Gain (Loss) from Changes in Non-Performance Risk on Market Risk Benefits** | **Total Accumulated Other Comprehensive Income (Loss)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, December 31, 2024 | $(1279) | $(197236) | $14809 | $48289 | $(135417) |
| Change in OCI before reclassifications | 673 | 80080 | (4368) | (6670) | 69715 |
| Amounts reclassified from AOCI | 0 | 3861 | 0 | 0 | 3861 |
| Income tax benefit (expense) | (133) | (17618) | 917 | 1401 | (15433) |
| Balance, September 30, 2025 | $(739) | $(130913) | $11358 | $43020 | $(77274) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** | **Accumulated Other Comprehensive Income (Loss)** |
| | **Foreign Currency Translation Adjustment** | **Net Unrealized Investment Gains (Losses)(1)** | **Interest Rate Remeasurement of Future Policy Benefits** | **Gain (Loss) from Changes in Non-Performance Risk on Market Risk Benefits** | **Total Accumulated Other Comprehensive Income (Loss)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, December 31, 2023 | $(1079) | $(130117) | $4369 | $79300 | $(47527) |
| Change in OCI before reclassifications | 184 | 32597 | (1894) | (10520) | 20367 |
| Amounts reclassified from AOCI | 0 | 799 | 0 | 0 | 799 |
| Income tax benefit (expense) | (47) | (7005) | 398 | 2209 | (4445) |
| Balance, September 30, 2024 | $(942) | $(103726) | $2873 | $70989 | $(30806) |

---

(1)Includes cash flow hedges of $(6) million and $12 million as of September 30, 2025 and December 31, 2024, respectively, and $4 million and $5 million as of September 30, 2024 and December 31, 2023, respectively*.*

60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Reclassifications out of Accumulated Other Comprehensive Income (Loss)***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| <u>Amounts reclassified from AOCI(1)(2):</u> |  |  |  |  |
| Net unrealized investment gains (losses): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flow hedges - Currency/Interest rate(3) | $703 | $(962) | $(1145) | $335 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized investment gains (losses) on available-for-sale securities | (1781) | (687) | (2716) | (1134) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net unrealized investment gains (losses)(4) | (1078) | (1649) | (3861) | (799) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total reclassifications for the period | $(1078) | $(1649) | $(3861) | $(799) |

---

(1)All amounts are shown before tax.

(2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI.

(3)See Note 4 for additional information on cash flow hedges.

(4)See table below for additional information on unrealized investment gains (losses), including the impact on future policy benefits, policyholders' account balances.

***Net Unrealized Investment Gains (Losses)***

Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company's Unaudited Interim Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from OCI those items that are included as part of "Net income (loss)" for a period that had been part of OCI in earlier periods. The amounts for the periods indicated below, split between amounts related to net unrealized investment gains (losses) on available-for-sale fixed maturity securities on which an allowance for credit losses has been recognized, and all other net unrealized investment gains (losses), are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Net Unrealized Investment Gains (Losses) on Available-for-Sale Fixed Maturity Securities on Which an Allowance for Credit Losses has been Recognized** | **Net Unrealized Gains (Losses) on All Other <br>Investments(1)** | **Other Costs(2)** | **Future Policy Benefits, Policyholders' Account Balances and Reinsurance Payables** | **Income Tax<br>Benefit (Expense)** | **Accumulated Other Comprehensive<br>Income (Loss) Related to Net Unrealized Investment Gains (Losses)** |
| | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| Balance, December 31, 2024 | $(19) | $(294601) | $(28133) | $73108 | $52409 | $(197236) |
| Net investment gains (losses) on investments arising during the period | 24 | 92033 | 0 | 0 | (19323) | 72734 |
| Reclassification adjustment for (gains) losses included in net income | 0 | 3861 | 0 | 0 | (810) | 3051 |
| Impact of net unrealized investment (gains) losses | 0 | 0 | 6215 | (18192) | 2515 | (9462) |
| Balance, September 30, 2025 | $5 | $(198707) | $(21918) | $54916 | $34791 | $(130913) |

---

(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges.

(2)"Other costs" primarily includes reinsurance recoverables and deposit receivables.

61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

**14.&nbsp;&nbsp;&nbsp;&nbsp;RELATED PARTY TRANSACTIONS**

The Company has extensive transactions and relationships with Prudential Insurance and other affiliates. Although we seek to ensure that these transactions and relationships are fair and reasonable, it is possible that the terms of these transactions are not the same as those that would result from transactions among unrelated parties.

***Expense Charges and Allocations***

The majority of the Company's expenses are allocations or charges from Prudential Insurance or other affiliates. These expenses can be grouped into general and administrative expenses and agency distribution expenses.

The Company's general and administrative expenses are charged to the Company using allocation methodologies based on business production processes. Management believes that the methodology is reasonable and reflects costs incurred by Prudential Insurance to process transactions on behalf of the Company. The Company operates under service and lease agreements whereby services of officers and employees, supplies, use of equipment and office space are provided by Prudential Insurance. The Company reviews its allocation methodology periodically which it may adjust accordingly. General and administrative expenses include allocations of stock compensation expenses related to a stock-based awards program and a deferred compensation program issued by Prudential Financial. The expense charged to the Company for the stock-based awards program was $0.0 million and $0.1 million for the three months ended September 30, 2025 and 2024, respectively, and $0.1 million for both the nine months ended September 30, 2025 and 2024. The expense charged to the Company for the deferred compensation program was $0.1 million for both the three months ended September 30, 2025 and 2024, and $0.4 million and $0.5 million for the nine months ended September 30, 2025 and 2024, respectively.

The Company is charged for its share of employee benefit expenses. These expenses include costs for funded and non-funded, non-contributory defined benefit pension plans. Some of these benefits are based on final earnings and length of service while others are based on an account balance, which takes into consideration age, service and earnings during a career. The Company's share of net expense for the pension plans was $0.3 million and $0.2 million for the three months ended September 30, 2025 and 2024, respectively, and $0.8 million and $0.6 million for the nine months ended September 30, 2025 and 2024, respectively.

The Company is also charged for its share of the costs associated with welfare plans issued by Prudential Insurance. These expenses include costs related to medical, dental, life insurance and disability. The Company's share of net expense for the welfare plans was $0.5 million and $0.4 million for the three months ended September 30, 2025 and 2024, respectively, and $1.3 million for both the nine months ended September 30, 2025 and 2024.

Prudential Insurance sponsors voluntary savings plans for its employee 401(k) plans. The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The Company's expense for its share of the voluntary savings plan was $0.2 million for both the three months ended September 30, 2025 and 2024, and $0.5 million for both the nine months ended September 30, 2025 and 2024.

The Company is charged distribution expenses from Prudential's proprietary nationwide sales organization, "Prudential Advisors" through a transfer pricing agreement, which is intended to reflect a market-based pricing arrangement. Prudential Advisors distributes Prudential life insurance, annuities, and investment products with proprietary and non-proprietary product options. In November 2024, the Company, along with three other affiliated entities, entered into several agreements with a third-party, LPL Financial Holdings Inc. ("LPL"). Under these agreements, the Company pays distribution expenses to LPL, of which 98% are returned to Prudential Advisors. Distribution expenses paid by the Company to LPL and subsequently returned to Prudential Advisors were $11 million for the three months ended September 30, 2025, and $33 million for the nine months ended September 30, 2025.

The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. ("PAD") in consideration for PAD's marketing and underwriting of the Company's annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company's annuity products. Commissions and fees paid by the Company to PAD were $13 million and $20 million for the three months ended September 30, 2025 and 2024, respectively, and $52 million and $54 million for the nine months ended September 30, 2025 and 2024, respectively.

62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The Company is charged for its share of corporate expenses incurred by Prudential Financial to benefit its businesses, such as advertising, executive oversight, external affairs and philanthropic activity. The Company's share of corporate expenses was $2 million and $3 million for the three months ended September 30, 2025 and 2024, respectively, and $7 million and $11 million for the nine months ended September 30, 2025 and 2024, respectively.

***Corporate-Owned Life Insurance***

The Company has sold three COLI policies to Prudential Insurance and one to Prudential Financial. The cash surrender value included in separate accounts for these COLI policies was $3,137 million and $2,861 million at September 30, 2025 and December 31, 2024, respectively. Fees related to these COLI policies were $7 million for both the three months ended September 30, 2025 and 2024, and $21 million and $20 million for the nine months ended September 30, 2025 and 2024, respectively. The Company reinsures 90% of the first $1 million of mortality risk associated with each individual policy to Pruco Life, and 100% of the mortality risk in excess of $1 million.

In May 2023, the Company funded a policy loan from the Prudential Financial COLI policy noted above in an amount of $900 million to an affiliated irrevocable trust, commonly referred to as a "rabbi trust", which Prudential Financial created to support certain non-qualified retirement plans. The outstanding balance of the policy loan with the rabbi trust was $890 million and $897 million as of September 30, 2025 and December 31, 2024, respectively. Interest income related to the policy loan was $10 million and $11 million for the three months ended September 30, 2025 and 2024, respectively, and $31 million and $32 million for the nine months ended September 30, 2025 and 2024, respectively.

***Affiliated Investment Management Expenses***

In accordance with an agreement with PGIM, Inc. ("PGIM"), the Company pays investment management expenses to PGIM who acts as investment manager to certain Company general account and separate account assets. Investment management expenses paid to PGIM related to this agreement were $0.8 million and $0.7 million for the three months ended September 30, 2025 and 2024, respectively, and $2.2 million and $2.0 million for the nine months ended September 30, 2025 and 2024, respectively. These expenses are recorded as "Net investment income" in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

***Derivative Trades***

In its ordinary course of business, the Company enters into OTC derivative contracts with an affiliate, PGF. For these OTC derivative contracts, PGF has a substantially equal and offsetting position with an external counterparty. See Note 4 for additional information.

***Joint Ventures***

The Company has made investments in joint ventures with certain subsidiaries of Prudential Financial. "Other invested assets" includes $83 million and $71 million of investments in joint ventures as of September 30, 2025 and December 31, 2024, respectively. "Net investment income" related to these ventures includes gains(losses) of $1.8 million and $0.8 million for the three months ended September 30, 2025 and 2024, respectively, and $3.3 million and $3.0 million for the nine months ended September 30, 2025 and 2024, respectively.

***Affiliated Asset Administration Fee Income***

The Company has a revenue sharing agreement with AST Investment Services, Inc. ("ASTISI") and PGIM Investments LLC ("PGIM Investments") whereby the Company receives fee income based on policyholders' separate account balances invested in the Advanced Series Trust. Income received from ASTISI and PGIM Investments related to this agreement was $6 million and $7 million for the three months ended September 30, 2025 and 2024, respectively, and $19 million and $20 million for the nine months ended September 30, 2025 and 2024, respectively. These revenues are recorded as "Asset administration fees" in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

The Company has a revenue sharing agreement with PGIM Investments, whereby the Company receives fee income based on policyholders' separate account balances invested in The Prudential Series Fund. Income received from PGIM Investments related to this agreement was $3 million and $2 million for the three months ended September 30, 2025 and 2024, respectively, and $8 million and $7 million for the nine months ended September 30, 2025 and 2024, respectively. These revenues are recorded as "Asset administration fees" in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).

***Affiliated Notes Receivable***

Affiliated notes receivable included in "Receivables from parent and affiliates" at September 30, 2025 and December 31, 2024 is as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Maturity Dates** | **Maturity Dates** | **Interest Rates** | **Interest Rates** | **September 30, 2025** | **December 31, 2024** |
| | | | | | **(in thousands)** | **(in thousands)** |
| U.S. dollar fixed rate notes | 2032 | 2033 | 0.00% | 10.00% | $25543 | $30135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total notes receivable - affiliated(1) |  |  |  |  | $25543 | $30135 |

---

(1)All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances.

The affiliated notes receivable shown above are classified as available-for-sale securities and other trading assets carried at fair value. The Company monitors the internal and external credit ratings of these loans and loan performance. The Company also considers any guarantees made by Prudential Insurance for loans due from affiliates.

Accrued interest receivable related to these loans was $0.0 million as of both September 30, 2025 and December 31, 2024, and is included in "Accrued investment income". Revenues related to these loans were $0.1 million for both the three months ended September 30, 2025 and 2024, and $0.1 million and $0.0 million for the nine months ended September 30, 2025 and 2024, respectively, and are included in "Other income (loss)".

***Affiliated Asset Transfers***

The Company participates in affiliated asset trades with parent and sister companies. Book and market value differences for trades with a parent and sister are recognized within "Additional paid-in capital" ("APIC") and "Realized investment gains (losses), net", respectively. The table below shows affiliated asset trades for the nine months ended September 30, 2025 and for the year ended December 31, 2024.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Affiliate** | **Date** | **Transaction** | **Security Type** | **Fair Value** | **Book Value** | **APIC, Net of Tax Increase/(Decrease)** | **Realized<br>Investment<br>Gain (Loss)** |
| | | | | **(in thousands)** | **(in thousands)** | **(in thousands)** | **(in thousands)** |
| PAR U | January 2024 | Transfer in | Fixed Maturities | $778745 | $778745 | $0 | $0 |
| PURE | January 2024 | Transfer out | Fixed Maturities | $778745 | $778745 | $0 | $0 |
| PAR U | June 2024 | Purchase | Commercial Mortgage and Other Loans | $12555 | $12555 | $0 | $0 |
| Hirakata | October 2024 | Purchase | Fixed Maturities | $3901 | $3901 | $0 | $0 |
| PAR U | October 2024 | Transfer in | Fixed Maturities | $632927 | $632927 | $0 | $0 |
| Pruco Life | October 2024 | Transfer out | Fixed Maturities | $632927 | $632927 | $0 | $0 |

---

64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Debt Agreements***

The Company is authorized to borrow funds up to $250 million from affiliates to meet its capital and other funding needs. There was no debt outstanding as of both September 30, 2025 and December 31, 2024.

The total interest expense to the Company related to loans payable to affiliates was $0.0 million for both the three months ended September 30, 2025 and 2024, and $0.0 million for both the nine months ended September 30, 2025 and 2024.

***Contributed Capital and Dividends***

In May and August 2025, the Company received capital contributions in the amount of $1.5 million and $3.6 million from Pruco Life, respectively. Through December 2024, the Company did not receive any capital contributions from Pruco Life.

Through September 2025 and December 2024, the Company did not pay any dividends to Pruco Life.

***Reinsurance with Affiliates***

As discussed in Note 11, the Company participates in reinsurance transactions with certain affiliates.

**15.&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENT LIABILITIES**

***Commitments***

The Company has made commitments to fund commercial mortgage and agricultural property loans. As of September 30, 2025 and December 31, 2024, the outstanding balances on these commitments were $7 million and $24 million, respectively. These amounts include unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of $0.0 million as of both September 30, 2025 and December 31, 2024, which is a change of $0.0 million for both the three and nine months ended September 30, 2025 and September 30, 2024. The Company also made commitments to purchase or fund investments, mostly fund investments and private fixed maturities, some of which are contingent upon events or circumstances not under the Company's control, including those at the discretion of the Company's counterparties. The Company anticipates a portion of these commitments will ultimately be funded from its separate accounts. As of September 30, 2025 and December 31, 2024, $118 million and $127 million, respectively, of these commitments were outstanding. These amounts include unfunded commitments that are not unconditionally cancellable. There were no related charges for credit losses for either the three or nine months ended September 30, 2025 or 2024.

***Contingent Liabilities***

On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines.

The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements.

It is possible that the results of operations or the cash flows of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flows for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company's financial position.

65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY** |
| **Notes to Unaudited Interim Financial Statements—(Continued)** |

---

***Litigation and Regulatory Matters***

The Company is subject to legal and regulatory actions in the ordinary course of its business. Pending legal and regulatory actions include proceedings specific to the Company and proceedings generally applicable to business practices in the industry in which it operates. The Company is subject to class action lawsuits and other litigation involving a variety of issues and allegations involving sales practices, claims payments and procedures, premium charges, policy servicing and breach of fiduciary duty to customers. The Company is also subject to litigation arising out of its general business activities, such as its investments, contracts, leases and labor and employment relationships, including claims of discrimination and harassment, and could be exposed to claims or litigation concerning certain business or process patents. In addition, the Company, along with other participants in the businesses in which it engages, may be subject from time to time to investigations, examinations and inquiries, in some cases industry-wide, concerning issues or matters upon which such regulators have determined to focus. In some of the Company's pending legal and regulatory actions, parties are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain.

The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established, but the matter, if material, is disclosed. The Company estimates that as of September 30, 2025, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $10 million. This estimate is not an indication of expected loss, if any, or the Company's maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews.

The following discussion of litigation and regulatory matters provides an update of those matters discussed in Note 16 to the Company's Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and should be read in conjunction with the complete descriptions provided in the Form 10-K.

***Summary***

The Company's litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company's results of operations or cash flows in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flows for such period. In light of the unpredictability of the Company's litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company's financial statements. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company's financial statements.

66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>**

*Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") addresses the financial condition of Pruco Life Insurance Company of New Jersey, or the "Company," as of September 30, 2025, compared with December 31, 2024, and its results of operations for the three and nine months ended September 30, 2025 and 2024. You should read the following analysis of our financial condition and results of operations in conjunction with the MD&A, the "Risk Factors" section, and the audited Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as well as the statements under "Forward-Looking Statements" and the Unaudited Interim Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.*

**Overview**

The Company is licensed to sell variable annuities, indexed variable annuities, fixed annuities, universal life insurance, variable life insurance and term life insurance in New Jersey and New York. The Company only sells such products in New York primarily through affiliated and unaffiliated distributors.

In August 2024, Pruco Life entered into an agreement with Wilton Reassurance Company and Wilton Reinsurance Bermuda Limited (collectively, "Wilton Re") to coinsure certain guaranteed universal life policies issued by PLNJ. As part of the transaction, the Company will coinsure the guaranteed universal life policies to Pruco Life, with retrocession by Pruco Life of such liabilities on a coinsurance basis to Wilton Re. The transaction is subject to regulatory approvals and customary closing conditions.

Effective January 2024, the Company entered into an agreement with Somerset Reinsurance Ltd. ("Somerset Re") to coinsure a closed block of guaranteed universal life ("GUL") policies to Prudential Universal Reinsurance Entity Company ("PURE"), a wholly-owned subsidiary of The Prudential Insurance Company of America ("Prudential Insurance"), with retrocession by PURE of such liabilities on a modified coinsurance basis, to Somerset Re. This transaction is effective as of January 1, 2024, whereby, the Company recaptured all risks associated with the subject GUL policies from Prudential Arizona Reinsurance Universal Company ("PAR U") and subsequently established yearly renewable term ("YRT") reinsurance for the subject GUL business with Prudential Insurance. See Note 11 to the Unaudited Interim Financial Statements for additional information.

**Regulatory Developments**

*Interest Maintenance Reserves*

In August 2025, the National Association of Insurance Commissioners ("NAIC") extended the temporary statutory accounting treatment of net negative interest maintenance reserves ("IMR") through December 31, 2026. This provision, which was set to expire on December 31, 2025, permits an insurer to admit net negative IMR up to 10% of their adjusted statutory surplus, provided such insurer's risk-based capital ("RBC") ratio remains above 300% of its Authorized Control Level RBC.

*H.R.1 — One Big Beautiful Bill Act (the "Tax Act of 2025")*

See Note 12 to the Unaudited Interim Financial Statements for information about tax law changes included in the Tax Act of 2025.

**Impact of Changes in the Interest Rate Environment**

As a financial services company, market interest rates are a key driver of our liquidity and capital positions, cash flows, results of operations and financial position. Changes in interest rates can affect these in several ways, including favorable or adverse impacts to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• investment-related activity, including: investment income returns, net investment spread results,

new money rates, mortgage loan prepayments and bond redemptions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the valuation of fixed income investments and derivative instruments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• collateral posting requirements, hedging costs and other risk mitigation activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customer account values and assets under management, including their impacts on fee-related income;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• insurance reserve levels, including market risk benefits ("MRBs"), and market experience true-ups;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• policyholder behavior, including surrender or withdrawal activity; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• product offerings, design features, crediting rates and sales mix.

67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

For additional information regarding interest rate risks, see "Risk Factors—Market Risk" included in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Revenues and Expenses**

The Company earns revenues principally from insurance premiums, mortality and expense fees, asset administration fees from insurance and investment products, and from net investment income on the investment of general account and other funds. The Company receives premiums primarily from the sale of individual life insurance and annuity products. The Company earns mortality and expense fees, and asset administration fees, primarily from the sale and servicing of universal life insurance and separate account products including variable life insurance and variable annuities. The Company's operating expenses principally consist of insurance benefits provided and reserves established for anticipated future insurance benefits, general business expenses, reinsurance premiums, commissions and other costs of selling and servicing the various products sold and interest credited on general account liabilities.

**Accounting Policies & Pronouncements**

**Application of Critical Accounting Estimates**

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP") requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews the estimates and assumptions used in the preparation of the Company's financial statements. If management determines that modifications to assumptions and estimates are appropriate given current facts and circumstances, the Company's results of operations and financial position as reported in the Unaudited Interim Financial Statements could change significantly.

Management believes the accounting policies relating to the following areas are most dependent on the application of estimates and assumptions and require management's most difficult, subjective, or complex judgments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Insurance liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Valuation of investments including derivatives, measurement of allowance for credit losses, and recognition of other-than-temporary impairments ("OTTI");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reinsurance recoverables;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Taxes on income; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves for contingencies, including reserves for losses in connection with unresolved legal matters

***Market Performance - Equity and Interest Rate Assumptions***

The liability for future policy benefits for certain of our universal life type products includes quarterly adjustments for the impact of changes to our estimate of future rates of returns on investments to reflect actual fund performance and market conditions. A portion of the returns on investments for our variable life contracts are dependent upon the total rate of return on assets held in separate account investment options. This rate of return influences the fees we earn and expected claims to be paid on variable life contracts, as well as other sources of profit. Returns that are higher than our expectations for a given period produce higher than expected account balances, which increase the future fees we expect to earn on variable life contracts and decrease expected claims to be paid on variable life contracts. The opposite occurs when returns are lower than our expectations.

68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The weighted average rate of return assumptions used in developing estimated market returns consider many factors specific to each product type, including asset durations, asset allocations and other factors. With regard to equity market assumptions, the near-term future rate of return assumption used in evaluating liabilities for future policy benefits for certain of our products, primarily our domestic variable life insurance products, is generally updated each quarter and is derived using a reversion to the mean approach, a common industry practice. Under this approach, we consider historical equity returns and adjust projected equity returns over an initial future period of five years (the "near-term") so that equity returns converge to the long-term expected rate of return. If the near-term projected future rate of return is greater than our near-term maximum future rate of return of 15.0%, we use our maximum future rate of return. If the near-term projected future rate of return is lower than our near-term minimum future rate of return of 0%, we use our minimum future rate of return. As of September 30, 2025, our variable life insurance businesses assume an 8.0% long-term equity expected rate of return and a 2.2% near-term mean reversion equity expected rate of return.

With regard to interest rate assumptions used in evaluating liabilities for future policy benefits for certain of our products, we generally update the long-term and near-term future rates used to project fixed income returns annually and quarterly, respectively. As a result of our 2025 annual reviews and update of assumptions and other refinements, we kept our long-term expectation of the 10-year U.S. Treasury rate unchanged and continue to grade to a rate of 3.5% over ten years. As part of our quarterly market experience updates, we update our near-term projections of interest rates to reflect changes in current rates.

For further discussion of impacts that could result from changes in these key estimates and assumptions, see "Management's Discussion and Analysis of Financial Condition and Results of Operations—Accounting Policies and Pronouncements—Application of Critical Accounting Estimates" in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Adoption of New Accounting Pronouncements**

See Note 2 to the Unaudited Interim Financial Statements for accounting pronouncements issued but not yet adopted and newly adopted accounting pronouncements.

**Changes in Financial Position**

Total assets increased $2.3 billion from $25.4 billion at December 31, 2024 to $27.7 billion at September 30, 2025. Significant components were:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total investments increased $1.0 billion driven by new sales of general account annuity products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reinsurance recoverables and deposit receivables increased $0.8 billion primarily driven by the reinsurance of indexed annuities to Prudential Insurance; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Separate account assets increased $0.5 billion primarily driven by favorable equity markets and net inflows for life products, partially offset by net outflows related to annuity products.

Total liabilities increased $2.2 billion from $24.2 billion at December 31, 2024 to $26.3 billion at September 30, 2025. Significant components were:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Policyholders' account balances increased $0.8 billion primarily driven by incremental indexed product sales; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reinsurance payables increased $0.6 billion primarily driven by the reinsurance of indexed annuities to Prudential Insurance.

Total equity increased $0.1 billion from $1.2 billion at December 31, 2024 to $1.3 billion at September 30, 2025, primarily driven by life net income.

69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Results of Operations**

**Income (loss) from Operations before Income Taxes**

***Three Months Comparison*** 

Income (loss) from operations before income taxes increased $22 million from income of $24 million for the three months ended September 30, 2024 to income of $46 million for the three months ended September 30, 2025 primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Higher Change in value of market risk benefits, net of related hedging gains (losses) due to changes in interest rates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Higher Net investment income due to net business growth driven by incremental indexed product sales.

Partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Higher Policyholders' benefits driven by reserve refinements for both the current and prior year periods related to term products; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lower Realized investment gains (losses), net driven by changes in interest rates.

***Nine Months Comparison*** Income (loss) from operations before income taxes increased $126 million from loss of $91 million for the nine months ended September 30, 2024 to income of $35 million for the nine months ended September 30, 2025. The impact from our annual reviews and update of assumptions and other refinements was a net gain of $10 million. Excluding the comparative impact of our annual reviews and update of assumptions and other refinements, income (loss) from operations increased $116 million primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lower Policyholders' benefits driven by the absence of the 2024 reinsurance recapture of the Company's GUL insurance policies.

Partially offset by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lower Policy charges and fee income driven by the absence of the 2024 reinsurance recapture of the Company's GUL insurance policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Lower Realized investments gains (losses), net from losses on indexed universal life ("IUL") embedded derivatives due to the increase in the present value of future index segment credits from lower rates.

**Revenues, Benefits and Expenses**

***Three Months Comparison***

Revenues increased $41 million from $55 million for the three months ended September 30, 2024 to $96 million for the three months ended September 30, 2025, primarily driven by the items mentioned above in Income (loss) from operations before income taxes.

Benefits and expenses increased $19 million from $31 million for the three months ended September 30, 2024 to $50 million for the three months ended September 30, 2025, primarily driven by the items mentioned above in Income (loss) from operations before income taxes.

***Nine Months Comparison***

Revenues decreased $381 million from revenues of $547 million for the nine months ended September 30, 2024 to revenues of $166 million for the nine months ended September 30, 2025. This includes an unfavorable comparative decrease of $31 million from our annual reviews and update of assumptions and other refinements. Excluding the comparative impact of our annual reviews and update of assumptions and other refinements, revenues decreased $350 million primarily driven by the items mentioned above in Income (loss) from operations before income taxes.

70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Benefits and expenses decreased $506 million from $638 million for the nine months ended September 30, 2024 to $132 million for the nine months ended September 30, 2025. This includes a favorable comparative decrease of $41 million from our annual reviews and update of assumptions and other refinements. Excluding the comparative impact of our annual reviews and update of assumptions and other refinements, benefits and expenses decreased $465 million primarily driven by the items mentioned above in Income (loss) from operations before income taxes.

*<u>Risks and Risk Mitigants:</u>*

*Indexed Variable Annuity Risks and Risk Mitigants.* The primary risk exposure of these indexed variable annuity products relates to the investment risks we bear in order to credit to the customer's account balance the required crediting rate based on the performance of the elected indices at the end of each term. We manage this risk primarily through our investment strategies including derivatives and product design features, which include credit rate resetting subject to contractual minimums as well as surrender charges applied during the early years of the contract that help to provide protection for premature withdrawals. In addition, our indexed variable annuity strategies have an interim value provision that provides protection from lapse in the case of rising interest rates.

*Variable Annuity Risks and Risk Mitigants.* The primary risk exposures of our variable annuity contracts relate to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including capital markets assumptions such as equity market returns, interest rates and market volatility, along with actuarial assumptions such as contractholder mortality, the timing and amount of annuitization and withdrawals, and contract lapses. For these risk exposures, achievement of our expected returns is subject to the risk that actual experience will differ from the assumptions used in the original pricing of these products. Prudential Financial, Inc. ("Prudential Financial") manages our exposure to certain risks driven by fluctuations in capital markets primarily through a combination of i) Product Design Features, and ii) our Asset Liability Management Strategy ("ALM"), as discussed below. Sales of traditional variable annuities with guaranteed living benefit riders were discontinued as of December 31, 2020.

*<u>Product Design Features:</u>*

A portion of the variable annuity contracts that we offer include an asset transfer feature. This feature is implemented at the contract level, and transfers assets between certain variable investment sub-accounts selected by the annuity contractholder and, depending on the benefit feature, a fixed-rate account in the general account or a bond fund sub-account within the separate account. The objective of the asset transfer feature is to reduce our exposure to equity market risk and market volatility. The asset transfer feature associated with highest daily living benefit products uses a designated bond fund sub-account within the separate account. The transfers are based on a static mathematical formula used with the particular benefit which considers a number of factors, including, but not limited to, the impact of investment performance on the contractholder's total account value. Other product design features we utilize include, among others, asset allocation restrictions, minimum issuance age requirements and certain limitations on the amount of purchase payments, as well as a required minimum allocation to our general account for certain of our products. In addition, there is diversity in our fee arrangements, as certain fees are primarily based on the benefit guarantee amount, the contractholder account value and/or premiums, which helps preserve certain revenue streams when market fluctuations cause account values to decline.

*<u>Asset Liability Management Strategy (including fixed income instruments and derivatives):</u>*

We employ an ALM strategy that utilizes a combination of both traditional fixed income instruments and derivatives to meet expected liabilities associated with our annuity guarantees. The MRB liability that we hedge consists of expected living and death benefit claims under various market conditions, which are managed using fixed income instruments, derivatives, or a combination thereof. For our Prudential Defined Income variable annuity, we utilize fixed income instruments to meet expected liabilities. For the portion of our ALM strategy executed with derivatives, we enter into a range of exchange-traded and over-the-counter ("OTC") equity, interest rate and credit derivatives, including, but not limited to: equity and treasury futures; total return, credit default and interest rate swaps; and options including equity options, swaptions, and floors and caps. The intent of this strategy is to more efficiently manage the capital and liquidity associated with these products while continuing to mitigate fluctuations in net income due to movements in capital markets. To achieve this, we periodically review and recalibrate the ALM strategy by optimizing the mix of derivatives and fixed income instruments to achieve expected outcomes.

**Income Taxes**

For information regarding income taxes, see Note 12 to the Unaudited Interim Financial Statements.

71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Liquidity and Capital Resources**

**Overview**

Liquidity refers to the ability to generate sufficient cash resources to meet the payment obligations of the Company. Capital refers to the long-term financial resources available to support the operations of our business, fund business growth, and provide a cushion to withstand adverse circumstances. Our ability to generate and maintain sufficient liquidity and capital depends on the profitability of our business, general economic conditions, our ability to borrow from affiliates and our access to the capital markets through affiliates as described herein.

Effective and prudent liquidity and capital management is a priority across the organization. Management monitors the liquidity of the Company on a daily basis and projects borrowing and capital needs over a multi-year time horizon. We use a Risk Appetite Framework ("RAF") to ensure that all risks taken by the Company align with our capacity and willingness to take those risks. The RAF provides a dynamic assessment of capital and liquidity stress impacts, including scenarios similar to, and more severe than, those occurring due to COVID-19, and is intended to ensure that sufficient resources are available to absorb those impacts. We believe that our capital and liquidity resources are sufficient to satisfy the capital and liquidity requirements of the Company.

Our businesses are subject to comprehensive regulation and supervision by domestic and international regulators. These regulations currently include requirements (many of which are the subject of ongoing rule-making) relating to capital and liquidity management. For information on these regulatory initiatives and their potential impact on us, see "Business—Regulation" and "Risk Factors" included in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Capital**

We manage the Company to regulatory capital levels consistent with our "AA" ratings targets. We utilize the risk-based capital ("RBC") ratio as a primary measure of capital adequacy. RBC is calculated based on statutory financial statements and risk formulas consistent with the practices of the National Association of Insurance Commissioners ("NAIC"). RBC considers, among other things, risks related to the type and quality of the invested assets, insurance-related risks associated with an insurer's products and liabilities, interest rate risks and general business risks. RBC ratio calculations are intended to assist insurance regulators in measuring an insurer's solvency and ability to pay future claims. The reporting of RBC measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities, but is available to the public. The Company's capital levels substantially exceed the minimum level required by applicable insurance regulations. Our regulatory capital levels may be affected in the future by changes to the applicable regulations, proposals for which are currently under consideration by both domestic and international insurance regulators.

The regulatory capital level of the Company can be materially impacted by interest rate and equity market fluctuations, changes in the values of derivatives, the level of impairments recorded, and credit quality migration of the investment portfolio, among other items. In addition, the reinsurance of business or the recapture of business subject to reinsurance arrangements due to defaults by, or credit quality migration affecting, the reinsurers or for other reasons could negatively impact regulatory capital levels. The Company's regulatory capital level is also affected by statutory accounting rules, which are subject to change by each applicable insurance regulator.

*Captive Reinsurance Companies:*

See "Management's Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources-Capital-Affiliated Captive Reinsurance Companies" included in our Annual Report on Form 10-K for the year ended December 31, 2024, for a discussion of our use of captive reinsurance companies.

72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Liquidity**

Our liquidity is managed to ensure stable, reliable and cost-effective sources of cash flows to meet all of our obligations. Liquidity is provided by a variety of sources, as described more fully below, including portfolios of liquid assets. Our investment portfolios are integral to the overall liquidity of the Company. We use a projection process for cash flows from operations to ensure sufficient liquidity to meet projected cash outflows, including claims. The impact of Prudential Funding, LLC's ("Prudential Funding"), a wholly-owned subsidiary of Prudential Insurance, financing capacity on liquidity (as described below) is considered in the internal liquidity measures of the Company.

Liquidity is measured against internally-developed benchmarks that take into account the characteristics of both the asset portfolio and the liabilities that they support. We consider attributes of the various categories of liquid assets (for example, type of asset and credit quality) in calculating internal liquidity measures to evaluate our liquidity under various stress scenarios, including company-specific and market-wide events. We continue to believe that cash generated by ongoing operations and the liquidity profile of our assets provide sufficient liquidity under reasonably foreseeable stress scenarios.

The principal sources of the Company's liquidity are premiums and certain annuity considerations, investment and fee income, investment maturities, sales of investments and internal borrowings. The principal uses of that liquidity include benefits, claims, and payments to policyholders and contractholders in connection with surrenders, withdrawals and net policy loan activity. Other uses of liquidity include commissions, general and administrative expenses, purchases of investments, the payment of dividends and returns of capital to the parent company, hedging and reinsurance activity and payments in connection with financing activities.

In managing liquidity, we consider the risk of policyholder and contractholder withdrawals of funds earlier than our assumptions when selecting assets to support these contractual obligations. We use surrender charges and other contract provisions to mitigate the extent, timing and profitability impact of withdrawals of funds by customers.

*Liquid Assets*

Liquid assets include cash and cash equivalents, short-term investments, U.S. Treasury fixed maturities, and fixed maturities that are not designated as held-to-maturity and public equity securities. As of September 30, 2025 and December 31, 2024, the Company had liquid assets of $3,633 million and $2,920 million, respectively. The portion of liquid assets comprised of cash and cash equivalents and short-term investments was $147 million and $182 million as of September 30, 2025 and December 31, 2024, respectively. As of September 30, 2025, $3,259 million, or 96%, of the fixed maturity investments in the Company's general account portfolios, were rated high or highest quality based on NAIC or equivalent rating.

*Prudential Funding, LLC*

Prudential Financial and Prudential Funding borrow funds in the capital markets primarily through the direct issuance of commercial paper. The borrowings serve as an additional source of financing to meet our working capital needs. Prudential Funding operates under a support agreement with Prudential Insurance whereby Prudential Insurance has agreed to maintain Prudential Funding's positive tangible net worth at all times.

*Term and Universal Life Reserve Financing* 

The Company uses affiliated captive reinsurance companies to finance the portion of the statutory reserves required to be held under Regulation XXX and Guideline AXXX that is considered to be non-economic. The financing arrangements involve the reinsurance of term and universal life business to our affiliated captive reinsurers and the issuance of surplus notes by those affiliated captives that are treated as capital for statutory purposes. These surplus notes are subordinated to policyholder obligations, and the payment of principal and interest on the surplus notes can only be made with prior insurance regulatory approval.

The affiliated captive reinsurance companies have entered into agreements with external counterparties providing for the issuance of surplus notes by our affiliated captive reinsurers in return for the receipt of credit-linked notes ("Credit-Linked Note Structures"). As of both September 30, 2025 and December 31, 2024, we had Credit-Linked Note Structures with an aggregate issuance capacity of $8,000 million to support Regulation XXX reserves, of which $7,560 million was outstanding and matures in 2044. These amounts exclude credit-linked note structures used to finance Guideline AXXX reserves for business reinsured to Somerset Re in March 2024. Under the agreements, the affiliated captive receives in exchange for the surplus notes one or more credit-linked notes issued by a special-purpose affiliate of the Company with an aggregate principal amount equal to the surplus notes outstanding. The affiliated captive holds the credit-linked notes as assets supporting Regulation XXX or Guideline AXXX non-economic reserves, as applicable.

73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

As of September 30, 2025, our affiliated captive reinsurance companies had outstanding an aggregate of $200 million of debt issued for the purpose of financing Regulation XXX non-economic reserves. In addition, as of September 30, 2025, for purposes of financing Guideline AXXX reserves, one of our affiliated captives had approximately $3,982 million of surplus notes outstanding that were issued to affiliates.

The Company has introduced updated versions of its individual life products in conjunction with the requirement to adopt principle-based reserving by January 1, 2020. These updated products are currently priced to support the principle-based statutory reserve level without the need for reserve financing.

**<u>Item 4. Controls and Procedures</u>**

In order to ensure that the information we must disclose in our filings with the Securities and Exchange Commission ("SEC") is recorded, processed, summarized, and reported on a timely basis, the Company's management, including our Chief Executive Officer and Chief Financial Officer, have reviewed and evaluated the effectiveness of our disclosure controls and procedures, as defined in Securities Exchange Act of 1934, as amended ("Exchange Act") Rule 15d-15(e), as of September 30, 2025. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2025, our disclosure controls and procedures were effective. No change in our internal control over financial reporting, as defined in Exchange Act Rule 15d-15(f), occurred during the quarter ended September 30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**PART II—OTHER INFORMATION**

**<u>Item 1. Legal Proceedings</u>**

See Note 15 to the Unaudited Interim Financial Statements under "—Litigation and Regulatory Matters" for a description of certain pending litigation and regulatory matters affecting us, and certain risks to our business presented by such matters, which is incorporated herein by reference.

**<u>Item 1A. Risk Factors</u>**

You should carefully consider the risks described under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024. These risks could materially affect our business, results of operations or financial condition or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by, or on behalf of, the Company. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under "Forward-Looking Statements" and the risks of our businesses described elsewhere in this Quarterly Report on Form 10-Q.

75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**<u>Item 6. Exhibits</u>**

---

| |
|:---|
| **EXHIBIT INDEX** |
| [31.1 Section 302 Certification of the Chief Executive Officer](plnj-20250930xex311.htm) |
| [31.2 Section 302 Certification of the Chief Financial Officer](plnj-20250930xex312.htm) |
| [32.1 Section 906 Certification of the Chief Executive Officer](plnj-20250930xex321.htm) |
| [32.2 Section 906 Certification of the Chief Financial Officer](plnj-20250930xex322.htm) |
| 101.INS - XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH - XBRL Taxonomy Extension Schema Document. |
| 101.CAL - XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB - XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE - XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF - XBRL Taxonomy Extension Definition Linkbase Document |
| 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3359dcf7e2124b3a87e46a6d66ad7397_7)</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| Pruco Life Insurance Company of New Jersey | Pruco Life Insurance Company of New Jersey |
| By: | /s/ Markus Coombs |
| Name: | Markus Coombs |
|  | Vice President and Chief Financial Officer |

---

Date: November 7, 2025

77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER**

I, Dylan J. Tyson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Pruco Life Insurance Company of New Jersey;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 7, 2025

---

| |
|:---|
| /s/ Dylan J. Tyson |
| Dylan J. Tyson |
| President and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF THE CHIEF FINANCIAL OFFICER**

I, Markus Coombs, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Pruco Life Insurance Company of New Jersey;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 7, 2025

---

| |
|:---|
| /s/ Markus Coombs |
| Markus Coombs |
| Vice President and Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER**

Pursuant to 18 U.S.C. § 1350, I, Dylan J. Tyson, President and Chief Executive Officer of Pruco Life Insurance Company of New Jersey (the "Company"), hereby certify that the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 7, 2025

---

| |
|:---|
| /s/ Dylan J. Tyson |
| Dylan J. Tyson |
| President and Chief Executive Officer |

---

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF THE CHIEF FINANCIAL OFFICER**

Pursuant to 18 U.S.C. § 1350, I, Markus Coombs, Vice President, Chief Financial Officer of Pruco Life Insurance Company of New Jersey (the "Company"), hereby certify that the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 7, 2025

---

| |
|:---|
| /s/ Markus Coombs |
| Markus Coombs |
| Vice President and Chief Financial Officer |

---

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

<br>